<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Psychological interventions for psychosis in adolescents - Datta, SS - 2020 | Cochrane Library</title> <meta content="Psychological interventions for psychosis in adolescents - Datta, SS - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009533.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Psychological interventions for psychosis in adolescents - Datta, SS - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009533.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009533.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Psychological interventions for psychosis in adolescents" name="citation_title"/> <meta content="Soumitra S Datta" name="citation_author"/> <meta content="ssdatta2000@yahoo.com" name="citation_author_email"/> <meta content="Rhea Daruvala" name="citation_author"/> <meta content="Tata Medical Centre" name="citation_author_institution"/> <meta content="Ajit Kumar" name="citation_author"/> <meta content="Latrobe Regional Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD009533.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/07/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009533.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009533.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009533.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Cognition [physiology]; *Cognitive Remediation; Combined Modality Therapy [methods]; *Family Therapy; Memory, Short-Term; Patient Dropouts [statistics &amp; numerical data]; *Psychotherapy, Group; Psychotic Disorders [*therapy]; Schizophrenia [*therapy]; Therapy, Computer-Assisted; Treatment Outcome; Video Games" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009533.pub2&amp;doi=10.1002/14651858.CD009533.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009533\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009533\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","th","ko","pt","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009533.pub2",title:"Psychological interventions for psychosis in adolescents",firstPublishedDate:"Jul 3, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009533.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009533.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009533.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009533.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009533.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009533.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009533.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009533.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009533.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009533.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9304 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009533.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0182"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0089"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-sec-0170"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/appendices#CD009533-sec-0192"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/table_n/CD009533StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/table_n/CD009533StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Psychological interventions for psychosis in adolescents</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information#CD009533-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Soumitra S Datta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information#CD009533-cr-0005">Rhea Daruvala</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information#CD009533-cr-0006">Ajit Kumar</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information/en#CD009533-sec-0202">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 July 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009533.pub2">https://doi.org/10.1002/14651858.CD009533.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009533-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009533-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009533-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009533-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009533-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009533-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD009533-abs-0003">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009533-abs-0001" lang="en"> <section id="CD009533-sec-0001"> <h3 class="title" id="CD009533-sec-0001">Background</h3> <p>Psychosis is an illness characterised by alterations in thoughts and perceptions resulting in delusions and hallucinations. Psychosis is rare in adolescents but can have serious consequences. Antipsychotic medications are the mainstay treatment, and have been shown to be effective. However, there is emerging evidence on psychological interventions such as cognitive remediation therapy, psycho‐education, family therapy and group psychotherapy that may be useful for adolescents with psychosis. </p> </section> <section id="CD009533-sec-0002"> <h3 class="title" id="CD009533-sec-0002">Objectives</h3> <p>To assess the effects of various psychological interventions for adolescents with psychosis. </p> </section> <section id="CD009533-sec-0003"> <h3 class="title" id="CD009533-sec-0003">Search methods</h3> <p>We searched the Cochrane Schizophrenia Group's study‐based Register of Trials including clinical trials registries (latest, 8 March 2019). </p> </section> <section id="CD009533-sec-0004"> <h3 class="title" id="CD009533-sec-0004">Selection criteria</h3> <p>All randomised controlled trials comparing various psychological interventions with treatment‐as‐usual or other psychological treatments for adolescents with psychosis. For analyses, we included trials meeting our inclusion criteria and reporting useable data. </p> </section> <section id="CD009533-sec-0005"> <h3 class="title" id="CD009533-sec-0005">Data collection and analysis</h3> <p>We independently and reliably screened studies and we assessed risk of bias of the included studies. For dichotomous data, we calculated risk ratios (RRs) and 95% confidence intervals (CIs) on an intention‐to‐treat basis. For continuous data, we used mean differences (MDs) and the 95% CIs. We used a random‐effects model for analyses. We created a ‘Summary of findings' table using GRADE. </p> </section> <section id="CD009533-sec-0006"> <h3 class="title" id="CD009533-sec-0006">Main results</h3> <p>The current review includes 7 studies (n = 319) assessing a heterogenous group of psychological interventions with variable risk of bias. Adverse events were not reported by any of the studies. None of the studies was sponsored by industry. Below, we summarise the main results from four of six comparisons, and the certainty of these results (based on GRADE). All scale scores are average endpoint scores. </p> <p><i>Cognitive Remediation Therapy (CRT) + Treatment‐as‐Usual (TAU) versus TAU</i> </p> <p>Two studies compared adding CRT to participants' TAU with TAU alone. Global state (CGAS, high = good) was reported by one study. There was no clear difference between treatment groups (MD ‐4.90, 95% CI ‐11.05 to 1.25; participants = 50; studies = 1, very low‐certainty). Mental state (PANSS, high = poor) was reported by one study. Scores were clearly lower in the TAU group (MD 8.30, 95% CI 0.46 to 16.14; participants = 50; studies = 1; very low‐certainty). Clearly more participants in the CRT group showed improvement in cognitive functioning (Memory digit span test) compared to numbers showing improvement in the TAU group (1 study, n = 31, RR 0.58, 95% CI 0.37 to 0.89; very low‐certainty). For global functioning (VABS, high = good), our analysis of reported scores showed no clear difference between treatment groups (MD 5.90, 95% CI ‐3.03 to 14.83; participants = 50; studies = 1; very low‐certainty). The number of participants leaving the study early from each group was similar (RR 0.93, 95% CI 0.32 to 2.71; participants = 91; studies = 2; low‐certainty). </p> <p><i>Group Psychosocial Therapy (GPT) + TAU versus TAU</i> </p> <p>One study assessed the effects of adding GPT to participants' usual medication. Global state scores (CGAS, high = good) were clearly higher in the GPT group (MD 5.10, 95% CI 1.35 to 8.85; participants = 56; studies = 1; very low‐certainty) but there was little or no clear difference between groups for mental state scores (PANSS, high = poor, MD ‐4.10, 95% CI ‐8.28 to 0.08; participants = 56; studies = 1, very low‐certainty) and no clear difference between groups for numbers of participants leaving the study early (RR 0.43, 95% CI 0.15 to 1.28; participants = 56; studies = 1; very low‐certainty). </p> <p><i>Cognitive Remediation Programme (CRP) + Psychoeducational Treatment Programme (PTP) versus PTP</i> </p> <p>One study assessed the effects of combining two types psychological interventions (CRP + PTP) with PTP alone. Global state scores (GAS, high = good) were not clearly different (MD 1.60, 95% CI ‐6.48 to 9.68; participants = 25; studies = 1; very low‐certainty), as were mental state scores (BPRS total, high = poor, MD ‐5.40, 95% CI ‐16.42 to 5.62; participants = 24; studies = 1; very low‐certainty), and cognitive functioning scores (SPAN‐12, high = good, MD 2.40, 95% CI ‐2.67 to 7.47; participants = 25; studies = 1; very low‐certainty). </p> <p><i>Psychoeducational (PE) + Multifamily Treatment (MFT) Versus Nonstructured Group Therapy (</i> NSGT<i>, all long‐term)</i> </p> <p>One study compared (PE + MFT) with NSGT. Analysis of reported global state scores (CGAS, high = good, MD 3.38, 95% CI ‐4.87 to 11.63; participants = 49; studies = 1; very low‐certainty) and mental state scores (PANSS total, high = poor, MD ‐8.23, 95% CI ‐17.51 to 1.05; participants = 49; studies = 1; very low‐certainty) showed no clear differences. The number of participants needing hospital admission (RR 0.84, 95% CI 0.36 to 1.96; participants = 49; studies = 1) and the number of participants leaving the study early from each group were also similar (RR 0.52, 95% CI 0.10 to 2.60; participants = 55; studies = 1; low‐certainty). </p> </section> <section id="CD009533-sec-0007"> <h3 class="title" id="CD009533-sec-0007">Authors' conclusions</h3> <p>Most of our estimates of effect for our main outcomes are equivocal. An effect is suggested for only four outcomes in the SOF tables presented. Compared to TAU, CRT may have a positive effect on cognitive functioning, however the same study reports data suggesting TAU may have positive effect on mental state. Another study comparing GPT with TAU reports data suggesting GPT may have a positive effect on global state. However, the estimate of effects for all the main outcomes in our review should be viewed with considerable caution as they are based on data from a small number of studies with variable risk of bias. Further data could change these results and larger and better quality studies are needed before any firm conclusions regarding the effects of psychological interventions for adolescents with psychosis can be made. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009533-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009533-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009533-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009533-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009533-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009533-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009533-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009533-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009533-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD009533-abs-0004">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009533-abs-0002" lang="en"> <h3>Psychological interventions for psychosis in adolescents</h3> <p><b>Review questions</b> </p> <p>Are psychological interventions effective and safe for adolescents with psychosis? Are there any differences in effect between different psychological interventions? </p> <p><b>Background</b> </p> <p>Psychosis is a mental illnesses characterised by alterations in thoughts and perceptions as delusions (false beliefs), hallucinations (seeing or hearing things that others do not see or hear) and can happen during adolescence. When this happens, the young person needs to see a mental health professional who will often prescribe medications. However, along with medications, adolescents with psychosis are likely to benefit from age‐appropriate psychological treatments (talking treatments) such as cognitive remediation therapy, psychoeducation, family therapy and group psychotherapy. These interventions can address social and psychological needs such as integration with peers and deal with the stigma and exclusion. We have reviewed the effects of these interventions for young people with psychosis using data from randomised controlled trials. </p> <p><b>Searching</b> <br/><br/>The Information Specialist of Cochrane Schizophrenia searched their trials register in May 2016 and March 2019 for trials that randomly allocated adolescents with psychosis to various treatment groups. The treatment groups could include either psychological interventions (with or without their usual treatment), medications alone, treatment‐as‐usual or other psychological interventions (with or without usual treatment).<br/><br/><b>Trials found</b><br/>This review includes only seven trials conducted in various parts of the world. The trials compared a variety of different psychological interventions with treatment‐as‐usual or with other types of psychological interventions, and they reported different outcome measures, making it difficult for us to compare one study with another. We were interested in the effect these treatments have on seven main outcomes: global state, mental state, adverse effects, cognitive functioning, global functioning, service use, and leaving the study early. None of the included studies reported adverse effect data. </p> <p><b>Results</b> </p> <p><b><i>Absolute effect of psychological interventions (PIs, comparing PIs with treatment‐as‐usual (TAU))</i> </b> </p> <p>Our analyses of reported data suggests that cognitive remediation therapy may help improve short term memory (a cognitive function) but treatment‐as‐usual may be better than CRT for improving mental state. Group therapy may be also be useful for improving global state. All other analyses for the main outcomes showed PIs had little or no effect compared to TAU. </p> <p><b><i>Relative effects of PIs (comparing one type of PI with another type of PI)</i> </b> </p> <p>Our analyses showed no real differences between the different types of PIs.</p> <p><b>Conclusions</b> </p> <p>Some psychological interventions may have beneficial effects for selected outcomes but, overall, most results suggest little or no effect. However, all our results were based on data from a very small number of studies with small numbers of participants. We also have concerns with the methods used in these studies. Thus, there is considerable uncertainty about the reliability of these findings. We cannot make firm conclusions based on this evidence. Relevant well‐conducted randomised controlled trials are needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009533-sec-0182" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009533-sec-0182"></div> <h3 class="title" id="CD009533-sec-0183">Implications for practice</h3> <section id="CD009533-sec-0183"> <section id="CD009533-sec-0184"> <h5 class="title">1. For adolescents with psychosis</h5> <p>Adolescents with psychosis often have many questions about their treatments that need to be addressed appropriately by their treating teams. Treatment with medications is often the mainstay of treatment for adolescents with psychosis but is outside the scope of the current review. There is very low‐quality evidence to suggest that group therapy may be useful for adolescents with psychosis in improving global state, mental state and quality of life. Cognitive remediation therapy may help short‐term memory in adolescents with psychosis based on very low‐quality evidence. The overall certainty of this evidence to support use of any modality of psychological therapy for adolescents with psychosis is currently very low making it difficult to be recommended for treatment of psychosis in adolescents. </p> </section> <section id="CD009533-sec-0185"> <h5 class="title">2. For managers and policy makers</h5> <p>There is insufficient evidence of high enough certainty to recommend any form of psychological therapy for adolescents with psychosis. There is very low‐certainty evidence supporting the use of group treatments for adolescents with psychosis and also very low‐certainty evidence to support the use of cognitive remediation therapy. </p> </section> <section id="CD009533-sec-0186"> <h5 class="title">3. For clinicians</h5> <p>While clinicians need to be sensitive to the psychological needs of adolescents with psychosis, the certainty of evidence for use of any form of psychological intervention is very low. While evidence is just emerging, there have been only a few studies on the effectiveness of cognitive remediation therapy, group therapy and family‐based interventions for adolescents with psychosis. Cognitive remediation therapy may help in the short‐term memory in adolescents with psychosis based on very low‐certainty evidence. Group therapy may be also useful for adolescents with psychosis in improving the global state, mental state and quality of life based on very low‐certainty of evidence. There is insufficient evidence of good quality to recommend any form of psychological therapy for adolescents with psychosis given that the adverse effects or harm caused by the therapies has not been reported at all by the studies. </p> </section> </section> <h3 class="title" id="CD009533-sec-0187">Implications for research</h3> <section id="CD009533-sec-0187"> <section id="CD009533-sec-0188"> <h5 class="title">1. General</h5> <p>Some of the studies did not adhere to the CONSORT guidelines while conducting or reporting their findings. As they have used a variety of outcome measures, it made it difficult for us to compare different studies. Future studies could be designed keeping this in mind and larger sample size should be used when using multiple outcome measures. Many studies were published several times by several authors and this should be avoided as it could potentially misguide clinicians. Quoting the trial identifiers for each publication will also help to reduce this, as has been suggested by other reviewers (<a href="./references#CD009533-bbs2-0185" title="RattehalliRD , ZhaoS , LiBG , JayaramMB , XiaJ , SampsonS . Risperidone versus placebo for schizophrenia. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD006918]">Rattehalli 2016</a>). </p> </section> <section id="CD009533-sec-0189"> <h5 class="title">2. Specific</h5> <p>Many of the studies that were excluded could potentially be included in reviews that cover young adults as opposed to adolescents. However, as one‐fifth of all patients with schizophrenia have onset prior to the age of 18 years, it is imperative that robust evidence is generated about psychological interventions for adolescents with psychosis. Also, not all psychosis in adolescents progresses to schizophrenia and psychological treatments may be more plausible for adolescents with psychosis as opposed to adults. We have recommended a study design for future research that addresses most of the problems we encountered in the existing literature (<a href="#CD009533-tbl-0007">Table 1</a>). Adolescents are different from young adults and this needs to be taken into account while designing studies. Almost always, this would require adult caregivers being available to give their feedback about the patient's illness. Robust measures of adverse events or potential harm caused by the psychological therapy should be part of the study design. Additional information from teachers and education‐related outcomes that are easily available due to statutory child protection legislation in many countries makes functional assessment more meaningful in adolescents than young adults with psychosis. </p> </section> </section> <div class="table" id="CD009533-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Design for a future study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: Randomised and described in detail in the study protocol and report. Appropriate measures to maintain allocation concealment needs to be implemented. </p> <p>Blinding: The trial should be double‐blind.</p> <p>Outcome Assessor: Researchers assessing outcome should be different from those who delivered the psychological interventions and should also be blind to the nature of the intervention. </p> <p>Duration: One year or more</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age: 13 to 18 years</p> <p>Gender: Equal representation of both genders</p> <p>Diagnosis: adolescents with psychosis as per clear operational criteria</p> <p>N = 200</p> <p>Setting: Outpatient setting is preferred. Patients requiring admission to inpatient adolescent units may not be an ideal group to received structured therapy. A combination of inpatient and outpatients will make the study population heterogenous. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Technique of psychotherapy: Cognitive remediation therapy, cognitive behaviour therapy, family therapy or group therapy. </p> <p>Duration of psychological intervention: at least 8 weeks</p> <p>Comparator: Treatment‐as‐usual</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcomes:</p> <p>Global state: Improved to significant degree</p> <p>Mental state: Significant clinical improvement as suggested by change of psychopathology score or relapse </p> <p>Global functioning: Significant change in global functioning as suggested by global functioning score or return to academic education or vocational training </p> <p>Leaving the study early: Intention‐to‐treat analysis should be conducted taking into account all participants in the intervention and comparator arms following randomisation even if they have left the study early. Comparative data for both groups should be presented. </p> <p>Service utilisation: Number of inpatient admissions and crisis presentations for one year following interventions </p> <p>Quality of life: Significant improvement in quality of life score</p> <p>Economic outcomes: Cost of interventions should be quantified.</p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009533-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009533-sec-0008"></div> <div class="table" id="CD009533-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">COGNITIVE REMEDIATION THERAPY (CRG) + TREATMENT‐AS‐USUAL (TAU) compared to TAU (all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COGNITIVE REMEDIATION THERAPY + TREATMENT‐AS‐USUAL compared to TREATMENT‐AS‐USUAL (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Inpatients and outpatients </p> <p><b>Intervention:</b> COGNITIVE REMEDIATION THERAPY + TREATMENT‐AS USUAL (CRT + TAU)<br/><b>Comparison:</b> TREATMENT‐AS‐USUAL (TAU) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TREATMENT‐AS‐USUAL (TAU)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COGNITIVE REMEDIATION THERAPY + TREATMENT‐AS‐USUAL (CRT + TAU)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Average endpoint score CGAS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the control group was 55.4 + 12.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the intervention group was</p> <p><b>4.9 lower</b><br/>(11.05 lower to 1.25 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state:</b> </p> <p>Average endpoint score PANNS (high score = poor)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score (PANSS) in the control group was 54.2 + 12.0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score (PANSS) in the intervention group was <b>8.30 higher</b> </p> <p>(0.46 higher to 16.14 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1,2,3,4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cognitive functioning: clinically important change</b> </p> <p>Not attaining normal cognitive function (Memory Digit Span)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/>(0.37 to 0.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>31<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>2,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1,000 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>580 per 1,000</b><br/>(370 to 890) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning:</b> </p> <p>Average endpoint VABS Score (high score = good)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint VABS score for the control arm was 73.5 + 19.5</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint VABS score for the intervention arm was <b>5.90 higher</b> (3.03 lower to 14.83 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>Very Low <sup>2,3,4,5,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Clinically important effect</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service use:</b> </p> <p>Hospital admission for any reason</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/>(0.32 to 2.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>91<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>2,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1,000</b><br/>(36 to 301) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (the results were imprecise with the estimated change in mean CGAS score and the mean PANSS score had a wide confidence interval). </p> <p><sup>2</sup> Downgraded by one level (the author reported that the study was a single‐blind study and likely the participants were not blind to the allocation status as the comparator arm was treatment‐as‐usual. This increased the risk of bias of the study findings). </p> <p><sup>3</sup> Downgraded by one level (binary outcome was unavailable. We therefore employed the mean endpoint CGAS score, PANSS score and Composite Cognitive score as alternative indicators). </p> <p><sup>4</sup> Downgraded by one level (majority of participants in one of the studies were recruited while they were inpatients. The comparator group was treatment‐as‐usual and the intervention arm was CRT. Therapists, patients and relatives were likely aware of the allocated arm. This design could pose a high risk of bias due to compromise in allocation concealment). </p> <p><sup>5</sup> Downgraded by one level (data used are from one trial with small sample size). </p> <p><sup>6</sup> Downgraded by one level (in one of the studies, there were fewer than 50% left the study early following randomisation. The study did not report the details of the intention‐to‐treat analysis). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009533-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU compared to TAU (all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GROUP PSYCHOSOCIAL THERAPY + TREATMENT‐AS‐USUAL compared to TREATMENT‐AS‐USUAL (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Outpatient<br/><b>Intervention:</b> GROUP PSYCHOSOCIAL THERAPY + USUAL MEDICATION (GPT + TAU)<br/><b>Comparison:</b> USUAL MEDICATION (TAU) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TREATMENT‐AS‐USUAL (TAU)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with GROUP PSYCHOSOCIAL THERAPY + TREATMENT‐AS‐USUAL (GPT + TAU)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Mean endpoint score (CGAS, high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the control group was</p> <p>49.7 + 6.8</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the intervention group was</p> <p><b>5.1 higher</b><br/>(1.35 higher to 8.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental State:</b> </p> <p>Mean endpoint total score on PANSS (high score = poor)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score PANSS total score in the</p> <p>control group was</p> <p>64.3 + 6.7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score PANSS total score in the intervention group was</p> <p><b>4.1 lower</b><br/>(8.28 lower to 0.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> </p> <p>Attaining normal cognitive functioning ‐ Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on mental state.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning</b>: </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on adverse events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service Use:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on service utilisation.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.43<br/>(0.15 to 1.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>132 per 1,000</b><br/>(46 to 394) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (the study did not report any details regarding random sequence generation and allocation concealment). </p> <p><sup>2</sup> Downgraded by one level (the study did not report any details regarding blinding of participants and assessors). </p> <p><sup>3</sup> Downgraded by one level (the authors have reported attrition in the intervention and control group and the number of participants who left the study early was fewer than 50%. However they have not been clear if the final analysis was done with intention‐to‐treat analysis where the outcome of all young people who were originally randomised were taken into account). </p> <p><sup>4</sup> Downgraded by one level (binary outcome was unavailable. We therefore used continuous scores on CGAS (Global state) and PANSS (mental state) as an alternative indicator). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009533-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">STRUCTURAL GROUP THERAPY (SGT) + TAU compared to HANDICRAFT GROUP (HC) + TAU (all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>STRUCTURAL GROUP THERAPY + TREATMENT‐AS‐USUAL compared to HANDICRAFT GROUP + TREATMENT‐AS‐USUAL (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Inpatient<br/><b>Intervention:</b> STRUCTURAL GROUP THERAPY + USUAL MEDICATION (SGT + TAU)<br/><b>Comparison:</b> HANDICRAFT GROUP + USUAL MEDICATION (HC + TAU) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with HANDICRAFT GROUP + TREATMENT‐AS‐USUAL (TAU)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with STRUCTURAL GROUP THERAPY + TRAETMENT‐AS‐USUAL (SGT + TAU)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global State:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global state.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental State:</b> </p> <p>Mean endpoint total score on PANSS (high score = poor)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint PANSS score in the control group was</p> <p>55.61 + 3.5</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint PANSS score in the intervention group was</p> <p><b>2.57 lower</b><br/>(4.47 lower to 0.67 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> Attaining normal cognitive functioning ‐ Not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on mental state.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning</b>: </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on adverse events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service Utilisation:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on service utilisation.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.71<br/>(0.25 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>233 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1,000</b><br/>(58 to 467) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (significant number but fewer than 50% of participants were lost to follow‐up over the course of the trial. No mention of intention‐to‐treat analysis was found in the paper). </p> <p><sup>2</sup> Downgraded by one level (binary outcome was unavailable. We therefore used continuous scores on PANSS (mental state) as an alternative indicator). </p> <p>3 Downgraded by one level (data obtained from only one trial that had a small sample size). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009533-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">COGNITIVE REMEDIATION PROGRAMME (CRP) + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) compared to PTP (all medium‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME compared to PSYCHOEDUCATIONAL TREATMENT PROGRAMME (all medium‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Inpatient<br/><b>Intervention:</b> COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP)<br/><b>Comparison:</b> PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with PSYCHOEDUCATIONALTREATMENT PROGRAMME (PTP)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Average endpoint score GAS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (GAS) in the control group was</p> <p>47.3 + 9.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (GAS) in the intervention group was <b>1.60 higher</b> </p> <p>(6.48 lower to 9.68 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low </p> <p><sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state:</b> </p> <p>Average endpoint score BPRS (high score = poor)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint BPRS scores in the control group was 43.3 + 14.6</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint BPRS scores in the intervention group was</p> <p><b>5.40 lower</b> </p> <p>(16.42 lower to 5.62 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> </p> <p>Mean endpoint score SPAN‐12 (high score = good)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint score on SPAN scores in the control group was 49.7 + 6.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint score on SPAN scores in the intervention group was</p> <p><b>2.40 higher</b> </p> <p>(2.67 lower to 7.47 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning:</b> </p> <p>Clinically important change ‐ as defined by each of the studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported useable data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects:</b> </p> <p>Clinically important adverse effect ‐ as defined by each of the studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported useable data on adverse events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service use:</b> </p> <p>Hospital admission for any reason</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported useable data for hospital admission.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early:</b> </p> <p>For any reason</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported data for leaving the study early.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (allocation concealment and blinding of participants and raters not well explained). </p> <p><sup>2</sup> Downgraded by one level (the authors analysed various outcome data for variable numbers of participants. Multiple outcome measures were reported but not all measures were completed by all participants. No intention‐to‐treat analysis was conducted and this posed a high risk of bias). </p> <p><sup>3</sup> Downgraded by one level (the sample size for the studies were small. The estimate of effect was not significant with a relatively wide confidence interval that crossed the line of no effect). </p> <p><sup>4</sup> Downgraded by one level (binary outcome was unavailable. We, therefore, employed BPRS score and Global State score as an alternative indicator). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009533-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) compared to COMPUTER GAMES (CG, all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME compared to COMPUTER GAMES (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Outpatients<br/><b>Intervention:</b> COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR)<br/><b>Comparison:</b> COMPUTER GAMES (CG) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COMPUTER GAMES (CG)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Average endpoint score HoNOSCA (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (HoNOSCA, 8 weeks) in the control group was 16.2 + 6.0 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (HoNOSCA, 8 weeks) in the intervention group was </p> <p><b>2.0</b> <b>higher</b><br/>(1.85 lower to 5.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state:</b> </p> <p>Average endpoint score PANNS (high score = poor)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint Mental state score (PANNS, 8 weeks) in the control group was 60.9 + 22.7 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint Mental state score (PANNS, 8 weeks) in the intervention group was</p> <p><b>3.7</b> <b>higher</b><br/>(10.68 lower to 18.08 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cognitive functioning:</b> </p> <p>Average endpoint score RBANS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score RBANS score (8 weeks) in the control group was 92.3 + 14.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score RBANS score (8 weeks) in the intervention group was</p> <p><b>8.7 lower</b><br/>(17.40 lower to 0.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global functioning</b>: Average endpoint score SOFAS (high score = good) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global functioning score (SOFAS, 8 weeks) in the control group was 52.8 + 10.7 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global functioning score (SOFAS, 8 weeks) in the intervention group was </p> <p><b>0.7 lower</b><br/>(7.76 lower to 6.36 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Clinically important change</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service use:</b> </p> <p>Hospital admission</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.33<br/>(0.27 to 20.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1,000</b><br/>(19 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (the participants for the intervention and control arm were trained by the same trainer. The sessions for both the groups were conducted in the same setting with the same frequency and duration. So the trainers and the adolescents were not blind to the group status. This confers high risk of bias, as allocation concealment may have been compromised, as the trainer and the adolescents were aware of the allocation status, although the outcome assessors were blind to the allocation status). </p> <p><sup>2</sup> Downgraded by one level (the sample size of participants randomised was only 24. The magnitude of changes in the mean score of PANSS and HoNOSCA at the endpoint were both small and the confidence intervals were very wide for the mean endpoint scores for both HoNOSCA and BPRS making the results imprecise). </p> <p><sup>3</sup> Downgraded by one level (the study did not report binary outcomes for mental state or cognitive functions. We therefore used continuous scores on HoNOSCA for global state, RBANS ‐ L (language) scores for cognitive functioning and SOFAS for global functioning as an alternative indicator). </p> <p>4 Downgraded by one level (significant number but fewer than 50% of participants were lost to follow‐up over the course of the trial). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009533-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">PSYCHOEDUCATIONAL (PE) + MULTIFAMILY TREATMENT (MFT) compared to NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT compared to NONSTRUCTURED INTERVENTION (all long‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Outpatient<br/><b>Intervention:</b> PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT)<br/><b>Comparison:</b> NONSTRUCTURED GROUP THERAPY (NSGT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NONSTRUCTURED GROUP THERAPY (NSGT)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Mean endpoint score CGAS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score on CGAS (104 weeks) in the control group was 70.67 + 13.6 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score on CGAS (104 weeks) in the intervention group was </p> <p><b>3.38 higher</b><br/>(4.87 lower to 11.63 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental State:</b> </p> <p>Mean end point score PANSS ‐ (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score on PANSS (104 weeks) in the control group was 53.58 + 18.23 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score on PANSS (104 weeks) in the intervention group was </p> <p><b>8.23 lower</b><br/>(17.51 lower to 1.05 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> Attaining normal cognitive functioning ‐ Not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on mental state.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning</b>: </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on adverse events.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Service use:</b> </p> <p>Number of participants needing admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/>(0.36 to 1.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>280 per 1,000</b><br/>(120 to 653) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.10 to 2.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>55<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1, 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1,000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1,000</b><br/>(14 to 371) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (therapists were the same for intervention and control groups for each type of clients and were thus not blind to status of the participants increasing the risk of bias). </p> <p><sup>2</sup> Downgraded by one level (although the study stated that the data were analysed using intention‐to‐treat analysis, it was strictly not the case at the end of two years, increasing the risk of bias). </p> <p><sup>3</sup> Downgraded by one level (the magnitude of change in the mean score of CGAS at the endpoint was small and the confidence intervals were very wide for the mean endpoint scores for CGAS, making the results imprecise). </p> <p><sup>4</sup> Downgraded by one level (binary outcome was unavailable. We therefore used continuous scores on CGAS (global state) and PANSS (mental state) as an alternative indicator). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009533-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009533-sec-0009"></div> <section id="CD009533-sec-0010"> <h3 class="title" id="CD009533-sec-0010">Description of the condition</h3> <p>Psychosis is an illness characterised by patients having alterations in thoughts and perceptions as delusions (false beliefs) and hallucinations (seeing or hearing things that others do not see or hear, <a href="./references#CD009533-bbs2-0139" title="GriswoldKS , Del RegnoPA , BergerRC . Recognition and Differential Diagnosis of Psychosis in Primary Care. Am Fam Physician Jun 15;91(12):856-63.">Griswold 2015</a>). Psychosis in adolescence is a rare but serious illness (<a href="./references#CD009533-bbs2-0178" title="Pencer Alissa, Addington Jean, Addington Donald. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Research2005;133(1):35-43.">Pencer 2005</a>). Patients with psychosis may have positive psychotic symptoms, especially delusions and hallucinations, and typically feature one or many comorbidities, including negative symptoms, mood symptoms, substance use disorders, medical diseases and PTSD (Post Traumatic Stress Disorder) (<a href="./references#CD009533-bbs2-0170" title="McGorryPD , KillackeyE , YungA . Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry2008;7(3):148-56.">McGorry 2008</a>). Adolescents with psychosis have difficulties in connecting with reality, may have hallucinations and delusions and deficits in cognitive capacities (<a href="./references#CD009533-bbs2-0206" title="VilaMF , GerberAJ . Cognitive Schemas and the Role of Attachment in Psychosis. In: McCarthyJB , editors(s). Psychosis in Childhood and Adolescence. 1st edition. New York: Routledge, 2015:47-59.">Vila 2015</a>). Young people with psychosis may have impairments across several cognitive domains such as processing speed, attention span and verbal memory (<a href="./references#CD009533-bbs2-0105" title="AngYG , TanHY . Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry research2004;121(3):303-7. [PMID: 14675749]">Ang 2004</a>, <a href="./references#CD009533-bbs2-0169" title="McCarthyJB , WeissSR , SegovichKT , BarbotB . Impact of psychotic symptoms on cognitive functioning in child and adolescent psychiatric inpatients with severe mood disorders. Psychiatry research2016;244:223-8. [PMID: 27497293]">McCarthy 2016</a>). These deficits impact on social and occupational functioning. A large population‐based study from Sweden (<a href="./references#CD009533-bbs2-0133" title="Gillberg Christopher, Wahlström Jan, Forsman Anders, Hellgren Lars, Gillberg I Carina. TEENAGE PSYCHOSES—EPIDEMIOLOGY, CLASSIFICATION AND REDUCED OPTIMALITY IN THE PRE-, PERI-AND NEONATAL PERIODS. Journal of Child Psychology and Psychiatry January 1986;27(1):87-98.">Gillberg 1986</a>) on young people aged 13 to 18 years of age has shown that the prevalence of psychosis in adolescents aged 13 years was 0.9 per 10,000 population and was 17.6 per 10,000 population at 18 years of age. However, a later study (<a href="./references#CD009533-bbs2-0180" title="PoultonR , CaspiA , MoffittTE , CannonM , MurrayR , Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry Nov 2000;57(11):1053-8.">Poulton 2000</a>) had suggested a much higher rate of up to 14% population prevalence of psychotic symptoms in 11 year‐old children. </p> <p>Currently, the concept of psychosis, as recognised by DSM‐V, emphasises that the boundaries between many of the psychotic disorder categories are fluid over the life course (<a href="./references#CD009533-bbs2-0107" title="American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders (DSM-V). 5th edition. Arlington, VA. APA2013.">APA 2013</a>). Likewise, in ICD‐11, it has been proposed that various psychotic disorders be classified under sections titled "schizophrenia spectrum and other primary psychotic disorders", "disorders due to substance use or addictive behaviours" and "secondary mental or behavioural syndromes associated with disorders or diseases classified elsewhere" (<a href="./references#CD009533-bbs2-0130" title="GaebelW , ReedGM . Status of psychotic disorders in ICD-11. Schizophrenia Bulletin2012;38(5):895-898.">Gaebel 2012</a>). Although not always clear at the outset, these psychotic symptoms in adolescents may be part of a serious illness like schizophrenia, psychotic affective disorders, or be more transient in nature such as substance‐induced psychosis (<a href="./references#CD009533-bbs2-0170" title="McGorryPD , KillackeyE , YungA . Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry2008;7(3):148-56.">McGorry 2008</a>; <a href="./references#CD009533-bbs2-0207" title="WerryJS , McClellanJM , ChardL . Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry1991;30(3):457-65.">Werry 1991</a>). </p> <p>Schizophrenia is a neurodevelopmental disorder (<a href="./references#CD009533-bbs2-0176" title="OwenMJ , O'DonovanMC , ThaparA , CraddockN . Neurodevelopmental hypothesis of schizophrenia. British Journal of Psychiatry2011;198(3):173-5.">Owen 2011</a>) which often has its onset during adolescence (<a href="./references#CD009533-bbs2-0110" title="BallageerT , MallaA , ManchandaR , TakharJ , HaricharanR . Is adolescent-onset first-episode psychosis different from adult onset?Journal of the American Academy of Child and Adolescent Psychiatry2005;44(8):782-9.">Ballageer 2005</a>). The DSM‐V criterion FOR schizophrenia includes the presence of two or more of the symptoms of delusions, hallucinations, disorganised speech, grossly disorganised behaviour and negative symptoms for a minimum period of one month, associated with impairment in one of the major areas of functioning and some signs of the disorder lasting for a continuous period of at least six months (<a href="./references#CD009533-bbs2-0107" title="American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders (DSM-V). 5th edition. Arlington, VA. APA2013.">APA 2013</a>). Onset OF schizophrenia between the ages of 13 to 17 years is known as adolescent‐onset schizophrenia (<a href="./references#CD009533-bbs2-0148" title="HollisCP . Adolescent schizophrenia. Advances in Psychiatric Treatment2000;6:83-92.">Hollis 2000a</a>; <a href="./references#CD009533-bbs2-0208" title="WerryJS . Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. Journal of Autism and Developmental Disorders1992;22(4):601-24.">Werry 1992</a>). The criteria for diagnosing schizophrenia in the adolescent age group are similar to the criteria used for adults with schizophrenia using ICD‐10 (International Classification of Diseases, 10th Revision) (<a href="./references#CD009533-bbs2-0212" title="World Health Organzation. ICD-10. In: The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.">WHO 1992</a>) and DSM‐V (<a href="./references#CD009533-bbs2-0107" title="American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders (DSM-V). 5th edition. Arlington, VA. APA2013.">APA 2013</a>). People with adolescent‐onset schizophrenia OFTEN have more affective symptoms and increased behaviour problems (<a href="./references#CD009533-bbs2-0207" title="WerryJS , McClellanJM , ChardL . Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry1991;30(3):457-65.">Werry 1991</a>), and may have a more severe and unremitting course with poorer outcome than adult‐onset schizophrenia (<a href="./references#CD009533-bbs2-0149" title="HollisCP . The adult outcomes of child and adolescent-onset schizophrenia: diagnostic stability and predictive validity. American Journal of Psychiatry2000;157:1653-9.">Hollis 2000b</a>). However, at times, there may be difficulties in differentiating juvenile‐onset bipolar disorder from non‐affective psychosis (<a href="./references#CD009533-bbs2-0196" title="SinghMK , KetterT , ChangKD . Distinguishing bipolar disorder from other psychiatric disorders in children. Current psychiatry reports2014;16(12):516. [PMID: 25315116]">Singh 2014</a>). Understandably, there is reticence among clinicians to make a formal diagnosis of schizophrenia in many cases, despite the reduced likelihood of a full or prolonged remission following first‐episode psychosis (<a href="./references#CD009533-bbs2-0149" title="HollisCP . The adult outcomes of child and adolescent-onset schizophrenia: diagnostic stability and predictive validity. American Journal of Psychiatry2000;157:1653-9.">Hollis 2000b</a>). </p> <p>Juvenile‐onset affective disorder may be associated with mood‐congruent psychotic symptoms. Psychotic symptoms are common in adolescents with mood disorders (<a href="./references#CD009533-bbs2-0103" title="AlgonS , YiJ , CalkinsME , KohlerC , Borgmann-WinterKE , . Evaluation and Treatment of Children and Adolescents with Psychotic Symptoms. Current Psychiatry Reports2012;14(2):101-110.">Algon 2012</a>). As many as 16 to 87.5% of young people with bipolar disorder and 4% of young people with major depressive disorder have reported coexisting psychotic symptoms (<a href="./references#CD009533-bbs2-0177" title="PavuluriMN , HerbenerES , SweeneyJA . Psychotic symptoms in pediatric bipolar disorder. J Affect Disord2004;80(1):19-28.">Pavuluri 2004</a>; <a href="./references#CD009533-bbs2-0204" title="UlloaRE , BirmaherB , AxelsonD , WilliamsonDE , BrentDA , RyanND , BridgeJ , BaugherM . Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates. J Am Acad Child Adolesc Psychiatry2000;39(3):337-345.">Ulloa 2000</a>). It is important to recognise psychotic symptoms in affective disorders in adolescents, as they may have poorer prognoses than those who have an affective disorder without psychotic symptoms (<a href="./references#CD009533-bbs2-0168" title="McCarthyJB , DobroshiZ . Major Depression, Bipolar Disorder and Psychosis in Children. Journal of Infant, Child, and Adolescent Psychotherapy2014;13(3):249-261.">McCarthy 2014</a>). </p> <p>Use of alcohol and Illicit drugs is not uncommon in adolescents and young people (<a href="./references#CD009533-bbs2-0171" title="MillerP , PlattM . Drinking, smoking and illicit drug use among 15 and 16 year olds in the United Kingdom. BMJ1996;313:394-397.">Miller 1996</a>). Psychosis in adolescents is often associated with cannabis and other illicit drug use (<a href="./references#CD009533-bbs2-0191" title="SchubartCD , Van GastelWA , BreetveltEJ , BeetzSL , OphoffRA , SommerIE , KahnRS , BoksMP . Cannabis use at a young age is associated with psychotic experiences. Psychological Medicine2010;41:1-10.">Schubart 2010</a>; <a href="./references#CD009533-bbs2-0216" title="ZammitS , LewisG , DalmanC , AllebeckP . Examining interactions between risk factors for psychosis. British Journal of Psychiatry2010;197(3):207-11.">Zammit 2010</a>). Rates of substance misuse among young people with first‐episode psychosis range from 25 to 60% (<a href="./references#CD009533-bbs2-0118" title="ComptonMT , BroussardB , RamsayCE , StewartT . Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis. Schizophr Res2011;126(1-3):71-76.">Compton 2011</a>; <a href="./references#CD009533-bbs2-0202" title="TuckerP . Substance misuse and early psychosis. Australas Psychiatry2009;17(4):291-294.">Tucker 2009</a>). A typical drug‐induced psychosis often remits following abstinence from the illicit drug (<a href="./references#CD009533-bbs2-0117" title="CatonCLM , DrakeRE , HasinDS , DominguezB , ShroutPE , SametS , SchanzerWB . Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Arch Gen Psychiatry2005;62(2):137-145.">Caton 2005</a>). Because of the severity of the psychotic symptoms, treatment for these young people often requires additional antipsychotic medications as well as psychological therapies (<a href="./references#CD009533-bbs2-0123" title="DriverD , GogtayN , RapoportJ . Childhood onset schizophrenia and early onset schizophrenia spectrum disorders. Child AdolescPsychiatric Clin N Am2013;22:539-555.">Driver 2013</a>; <a href="./references#CD009533-bbs2-0150" title="ImranS , DattaSS , VincentE , WhitfieldJ , ClarkA . Antipsychotic prescribing: old wine in new bottles?Child and Adolescent Mental Health Nov 2011;16(4):218-221.">Imran 2011</a>). However, cannabis use by the age of 15 years can be associated with increased risk of psychosis in adult life as well (<a href="./references#CD009533-bbs2-0108" title="ArseneaultL , CannonM , WittonJ , MurrayRM . Causal association between cannabis and psychosis: examination of the evidence. BJP2004;184:110-117.">Arseneault 2004</a>). </p> <p>It must be noted that 'childhood‐onset' (<a href="./references#CD009533-bbs2-0107" title="American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders (DSM-V). 5th edition. Arlington, VA. APA2013.">APA 2013</a>) or 'very early onset' schizophrenia, that is, schizophrenia occurring below the age of 13, is extremely rare and will not be considered directly here. Childhood‐onset schizophrenia has been reviewed separately by some of the authors of the current review (<a href="./references#CD009533-bbs2-0152" title="KennedyE , KumarA , DattaSS . Antipsychotic medication for childhood-onset schizophrenia. Schizophrenia Bulletin2007;33(5):1082-3.">Kennedy 2007</a>; <a href="./references#CD009533-bbs2-0153" title="KennedyE , KumarA , DattaSS . Antipsychotic medication for childhood-onset schizophrenia. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD004027.pub2]">Kennedy 2007a</a>). </p> <p>Late adolescence is a critical period in brain development and this may make this age group particularly vulnerable to onset of schizophrenia (<a href="./references#CD009533-bbs2-0135" title="GogtayN , VyasNS , TestaR , WoodSJ , PantelisC . Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophrenia Bulletin2011;37(3):504-13.">Gogtay 2011</a>; <a href="./references#CD009533-bbs2-0184" title="RapoportJL , GogtayN . Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. International Journal of Developmental Neuroscience2011;29(3):251-8.">Rapoport 2011</a>). There needs to be well developed evidence‐based treatment protocols for the adolescents with psychosis (<a href="./references#CD009533-bbs2-0156" title="KilneE , SchiffmanJ , ChoiJ , LaitnerC , RogoveJ . Evidence-based practice and childhood psychosis. In: McCarthyJ , editors(s). Psychosis in childhood and adolescence. 1st edition. New York: Routledge, 2015:192-215.">Kline 2015</a>). Psychiatric assessment of adolescents requires the clinician to obtain a longitudinal clinical history from the caregivers as well as the young person and also conduct a detailed mental state examination (<a href="./references#CD009533-bbs2-0155" title="KingRA . Practice Parameters for the Psychiatric Assessment of Children and Adolescents. Journal of the American Academy of Child &amp; Adolescent Psychiatry1997;36(10):4S-20S. [DOI: 10.1097/00004583-199710001-00002]">King 1997</a>).The point of intervening appropriately for adolescents with psychosis is to delay or prevent the onset of schizophrenia and other chronic severe mental illnesses, reduce psychological distress, provide symptom relief and reduce the incidence of high risk behaviours as completed suicide, self harm, posing harm to others and, by all this, foster a good therapeutic relationship with clinical teams early on in life (<a href="./references#CD009533-bbs2-0167" title="MarshallM , RathboneJE . Early intervention for psychosis. Cochrane Database of Systematic Reviews2011;6:Art. No.: CD004718.">Marshall 2011</a>). Possible treatment options for adolescents with psychosis include medications, psychological treatments and social rehabilitation. </p> </section> <section id="CD009533-sec-0011"> <h3 class="title" id="CD009533-sec-0011">Description of the intervention</h3> <p>Psychological interventions include a wide range of treatment which can be administered on an individual or group basis that aim to modify behaviour, emotions or feelings (<a href="./references#CD009533-bbs2-0111" title="BallouMB . Psychological interventions: A guide to strategies.. Westport CT: Praeger Publishers, 1995.">Ballou 1995</a>). The National Institute of Health and Clinical Excellence (NICE) Guidelines recommends the use of psychological interventions in routine care of young people with psychosis and schizophrenia (<a href="./references#CD009533-bbs2-0173" title="NICE: National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management. CG 1552013.">NICE 2013</a>). The recommendations include guidelines for managing transient or attenuated psychotic symptoms, first‐episode psychosis, subsequent acute episodes of psychosis or schizophrenia, managing crisis situations, early post‐acute period and facilitating recovery of a young person with psychosis. The importanceof psychological interventions has been mentioned several times in the NICE guidelines which discuss the role of CBT (cognitive behaviour therapy) and family‐based interventions in young people with psychosis, taking into consideration preferences of the patients and their families. A recent audit of mental health teams for adults in the UK showed that there was a positive attitude towards using psychological therapies (<a href="./references#CD009533-bbs2-0181" title="PrytysM , GaretyPA , JolleyS , OnwumereJ , CraigT . Implementing the NICE guideline for schizophrenia recommendations for psychological therapies: a qualitative analysis of the attitudes of CMHT staff. Clinical Psychology &amp; Psychotherapy2011;18(1):48-59.">Prytys 2011</a>). </p> <p>In a review on early psychosis, <a href="./references#CD009533-bbs2-0142" title="HaddockG , LewisS . Psychological interventions in early psychosis. Schizophrenia Bulletin2005;31(3):697-704.">Haddock 2005</a> mentions the focus of psychological interventions could be: a) interventions focussing on the prodromal or 'high‐risk' phase of early psychosis, where the individual does not have 'full‐blown' psychotic symptoms and the person does not meet the criteria for a psychotic illness; b) interventions focussing on the period of first‐episode psychosis when the individual has definite psychotic symptoms; c) interventions focussing on recovery from first‐episode psychosis; d) interventions addressing comorbid symptoms and issues associated with first‐episode psychosis as substance misuse, affective symptoms, etc. The current review will cover the latter three groups relevant to adolescents with established psychosis. </p> <p>i. Cognitive Remediation Therapy (CRT), individual or computer‐assisted</p> <p>Studies on Cognitive Remediation Therapy (CRT) or Cognitive Remediation Therapy Programme (CRP) have focussed on improving cognitive symptoms and functioning (<a href="./references#CD009533-bbs2-0128" title="FrazierJA , GiulianoAJ , JohnsonJL , YakutisL , YoungstromEA , BreigerD , SikichL , FindlingRL , McClellanJ , HamerRM , VitielloB , LiebermanJA , Hooper SR. Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.. Journal of the American Academy of Child and Adolescent Psychiatry2012;51(5):496-505.">Frazier 2012a</a>; <a href="./references#CD009533-bbs2-0156" title="KilneE , SchiffmanJ , ChoiJ , LaitnerC , RogoveJ . Evidence-based practice and childhood psychosis. In: McCarthyJ , editors(s). Psychosis in childhood and adolescence. 1st edition. New York: Routledge, 2015:192-215.">Kline 2015</a>). The goal of this treatment is to improve cognitive functioning in specific domains such as processing speed, verbal memory and other cognitive domains and, in doing so, also improve the person's social and occupational functioning. In keeping with the increasing use of technology, computer‐assisted cognitive remediation therapy through the use of mobile devices has been tested in the delivery of CRT (<a href="./references#CD009533-bbs2-0113" title="BäumlJ , FroböseT , KraemerS , RentropM , Pitschel-WalzG . Psychoeducation: A Basic Psychotherapeutic Intervention for Patients With Schizophrenia and Their Families. Schizophrenia Bulletin2006;32(Suppl 1):s1-s9.">Baum 2006</a>). </p> <p>ii. Cognitive Behaviour therapy (CBT), individual or group</p> <p>Cognitive Behaviour Therapy (CBT) incorporates principles of behaviour modification and cognitive techniques to challenge maladaptive thinking. CBT has been used for a variety of psychiatric diagnoses in adolescents (<a href="./references#CD009533-bbs2-0199" title="StallardP . A clinicians guide to think good - feel good. Chichester: John Wiley &amp; Sons, Ltd, 2005.">Stallard 2005</a>) and adults (<a href="./references#CD009533-bbs2-0143" title="HawtonK , SalkovoskiPM , KirkJ , ClarkDM . Cognitive Behaviour Therapy for Psychiatric Problems: A Practical Guide (Oxford Medical Publications). 1 edition. Oxford: Oxford University Press, 1989.">Hawton 1989</a>; <a href="./references#CD009533-bbs2-0157" title="KuipersE , GaretyPA , FowlerD , DunnG , BebbingtonP , Freeman D et al. The London-East Anglia randomised controlled trial of cognitive behavior therapy for psychosis, I: Effects of treatment phase. Br J Psychiatry1997;171:319-27.">Kuipers 1997</a>).Cognitive Behaviour Therapy (CBT) for psychosis addresses positive psychotic symptoms such as hallucinations or delusions, negative symptoms such as apathy, avolition or amotivation and re‐training executive functions (<a href="./references#CD009533-bbs2-0172" title="Morrison AnthonyP , Barratt Sarah. What Are the Components of CBT for Psychosis? A Delphi Study. Schizophrenia Bulletin2010;36(1):136-42.">Morrison 2010</a>). CBT may also address comorbid affective symptoms and substance misuse problems. CBT can be offered to individuals or groups. </p> <p>iii. Family‐based interventions</p> <p>Family‐based interventions focus on reducing expressed emotions and improving acceptance of the illness by the family members of the patient. In family therapy, the therapist addresses the family as a unit. During systemic family therapy, relationships between family members are assessed and reducing expressed emotions of close family members towards the patient was shown to reduce the possibility of relapse of psychosis (<a href="./references#CD009533-bbs2-0160" title="LeffJ , BerkowitzR , ShavitN , StrachanA , GlassI , Vaughn C. A trial of family therapy v. a relatives group for schizophrenia.. Br J Psychiatry1989;154:58-66.">Leff 1989</a>). Understanding the systems and subsystems of the family helps the family to change for the better (<a href="./references#CD009533-bbs2-0112" title="BarkerP , ChangJ . Models for the Assessment of Families. In: BarkerP , ChangJ , editors(s). Basic Family Therapy. 6th edition. London: John Wiley &amp; Sons, Ltd, 2013:57-69.">Barker 2013</a>). Family therapy aims to encourage open communication, partnership and collaboration among family members. Family therapy has been undertaken in outpatients and inpatients (<a href="./references#CD009533-bbs2-0134" title="GlickID , ClarkinJF , HaasGL , Spencer JH Jr. Clinical significance of inpatient family intervention: conclusions from a clinical trial.. Hosp Community Psychiatry1993;44:869-73.">Glick 1993</a>). It has been used for adults with schizophrenia (<a href="./references#CD009533-bbs2-0158" title="KuipersE , LeffJ , LamD . Family work for schizophrenia: A practical guide. London: Gaskell Press, 2002.">Kuipers 2002</a>) and adolescents with psychosis (<a href="./references#CD009533-bbs2-0156" title="KilneE , SchiffmanJ , ChoiJ , LaitnerC , RogoveJ . Evidence-based practice and childhood psychosis. In: McCarthyJ , editors(s). Psychosis in childhood and adolescence. 1st edition. New York: Routledge, 2015:192-215.">Kline 2015</a>). It is usually delivered over five to six weekly sessions (<a href="./references#CD009533-bbs2-0112" title="BarkerP , ChangJ . Models for the Assessment of Families. In: BarkerP , ChangJ , editors(s). Basic Family Therapy. 6th edition. London: John Wiley &amp; Sons, Ltd, 2013:57-69.">Barker 2013</a>). </p> <p>iv. Adherence‐improvement therapy</p> <p>Treatment‐adherence therapies mainly try to improve insight and, in addition, may use behavioural approaches to improve adherence to medications and engagement with services. Adherence to medications, regular clinical reviews, monitoring and reporting of side effects of treatments and psychological interventions are all likely to impact the overall outcome of young people with psychosis (<a href="./references#CD009533-bbs2-0131" title="Gearing Robin Edward, Mian IrfanA . An Approach to Maximizing Treatment Adherence of Children and Adolescents with Psychotic Disorders and Major Mood Disorders. The Canadian child and adolescent psychiatry review2005;14(4):106-13.">Gearing 2005</a>). Nonadherence to treatment is a major clinical problem for young people on long‐term medications (<a href="./references#CD009533-bbs2-0189" title="SalemaNE , ElliottRA , Glazebrook C. A systematic review of adherence-enhancing interventions in adolescents taking long-term medicines. J Adolesc Health2011;49(5):455-66.">Salema 2011</a>). Adherence‐improvement therapy usually has an educational component that may be delivered in face‐to‐face therapy sessions, through printed educational material, showing videos or any other medium of communication (<a href="./references#CD009533-bbs2-0131" title="Gearing Robin Edward, Mian IrfanA . An Approach to Maximizing Treatment Adherence of Children and Adolescents with Psychotic Disorders and Major Mood Disorders. The Canadian child and adolescent psychiatry review2005;14(4):106-13.">Gearing 2005</a>). Some therapists have tried to improve adherence by empowering young people to participate more actively in their disease management, increasing social support through peers, providing incentives for behaviour change, and improving the acceptability of treatment (<a href="./references#CD009533-bbs2-0189" title="SalemaNE , ElliottRA , Glazebrook C. A systematic review of adherence-enhancing interventions in adolescents taking long-term medicines. J Adolesc Health2011;49(5):455-66.">Salema 2011</a>). </p> <p>v. Psychoeducation</p> <p>Psychoeducation involves didactic skilful communication of key information about a disorder with the patient and their family in order to empower patients to be knowledgeable and engaged with the larger treatment programme. The process of psychoeducation involves educating patients and their family members and answering questions that they may have about the illness. The patient and family is given information on treatment adherence and other topics such as aetiology of the illness, that are crucial in engagement and recovery of a young person with psychosis (<a href="./references#CD009533-bbs2-0132" title="Gearing Robin Edward. Evidence-Based Family Psychoeducational Interventions for Children and Adolescents with Psychotic Disorders. Journal of the Canadian Academy of Child and Adolescent Psychiatry2008;17(1):2-11.">Gearing 2008</a>). Timely and well balanced psychoeducation reduces the possibility of relapse of psychosis and is likely to improve coping of the adult patients with schizophrenia and their family (<a href="./references#CD009533-bbs2-0179" title="Pitschel-WalzG , LeuchtS , BäumlJ , KisslingW , Engel RR. The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. Schizophr Bull2001;27(1):73-92.">Pitschel‐Walz 2001</a>). Psychoeducation can be delivered as part of an office‐based family therapy or in a multi‐group family setting for adolescents and be part of a therapy following a cognitive behavioural therapy paradigm (<a href="./references#CD009533-bbs2-0113" title="BäumlJ , FroböseT , KraemerS , RentropM , Pitschel-WalzG . Psychoeducation: A Basic Psychotherapeutic Intervention for Patients With Schizophrenia and Their Families. Schizophrenia Bulletin2006;32(Suppl 1):s1-s9.">Baum 2006</a>; <a href="./references#CD009533-bbs2-0187" title="RuffoloMC , KuhnMT , Evans ME. Support, empowerment, and education: A study of multiple family group education. Journal of Emotional and Behavioral Disorders2005;13(4):200-212.">Ruffolo 2005</a>). </p> <p>vi. Group therapy</p> <p>In group psychotherapy, one or more therapists treat a group of patients together following the principles of CBT, behaviour therapy (such as relaxation training and social skills training), psychoeducation in groups or any other acceptable psychological technique that has been used successfully in a group setting. Group therapy involves one or more therapists seeing a small number of patients in a group. Literature has highlighted the therapeutic value of group processes over and above client‐therapist interactions in a group therapy setting (<a href="./references#CD009533-bbs2-0214" title="YalomID , LeszczM . The theory and practice of group psychotherapy. 5th edition. New York: Basic books, 2005.">Yalom 2005</a>). Groups can be run by trained therapists in line with CBT, psychodynamic or other paradigms. They could be open or closed groups where new membership is restricted once the group work has begun. Groups often meet in the presence of a therapist at scheduled intervals over the course of a few months. Group therapy has been used for a variety of problems in adults with psychosis (<a href="./references#CD009533-bbs2-0141" title="GumleyA , WhiteR , BriggsA , FordI , BarryS , StewartC , BeedieS , McTaggartJ , ClarkeC , MacLeodR , LidstoneE , RiverosBS , YoungR , McLeod H. A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for depression after psychosis: Pilot trial outcomes (ADAPT). Schizophr Res2016;Advanced online access:Early view.">Gumley 2016</a>). </p> <p>Delivery of psychological therapy need to standardised in terms of: a) therapy quality (the extent to which the therapy was delivered well enough) and b) therapist competence (capacity of the therapist to deliver treatment in terms of knowledge and skills, <a href="./references#CD009533-bbs2-0127" title="Fairburn ChristopherG , Cooper Zafra. Therapist competence, therapy quality, and therapist training. Behaviour Research and Therapy2011;49(6-7):373-8.">Fairburn 2011</a>). The above therapies were compared with each other or with standard care. </p> </section> <section id="CD009533-sec-0012"> <h3 class="title" id="CD009533-sec-0012">How the intervention might work</h3> <p>There is robust evidence to show that psychosis has a bio‐psycho‐social basis (<a href="./references#CD009533-bbs2-0145" title="HenquetC , Di FortiM , MorrisonP , KuepperR , MurrayRM . Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin2008;34(6):1111-21. [PMID: 18723841]">Henquet 2008</a>; <a href="./references#CD009533-bbs2-0200" title="ThewissenV , BentallRP , OorschotM , A CampoJ , Van LieropT , vanOsJ , Myin-GermeysI . Emotions, self-esteem, and paranoid episodes: an experience sampling study. British Journal of Clinical Psychology2011;50(2):178-95. [PMID: 21545450]">Thewissen 2011</a>). Psychological therapies, in the form of supportive counselling make the treatment programme patient‐centred (<a href="./references#CD009533-bbs2-0137" title="GondekD , Edbrooke-ChildsJ , VelikonjaT , ChapmanL , SaundersF , HayesD , Wolpert M. Facilitators and Barriers to Person-centred Care in Child and YoungPeople Mental Health Services: A Systematic Review. Clin Psychol Psychother2017;24(4):870-886.">Gondek 2017</a>). Psychological interventions for psychosis almost always have a component of psychoeducation, that empowers the patient and their caregivers to understand the illness better, help the young person engage with the treating team more meaningfully, ensure safety and likely improve medication adherence (<a href="./references#CD009533-bbs2-0156" title="KilneE , SchiffmanJ , ChoiJ , LaitnerC , RogoveJ . Evidence-based practice and childhood psychosis. In: McCarthyJ , editors(s). Psychosis in childhood and adolescence. 1st edition. New York: Routledge, 2015:192-215.">Kline 2015</a>). </p> <p>It has been hypothesised that CBT in adults with depression produces new learning through synaptogenesis (formation of connections between various neurons) (<a href="./references#CD009533-bbs2-0136" title="GoldappleK , SegalZ , GarsonC , LauM , BielingP , KennedyS , MaybergH . Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry2004;61(1):34-41.">Goldapple 2004</a>, <a href="./references#CD009533-bbs2-0215" title="YangY , KircherT , Straube B. The neural correlates of cognitive behavioraltherapy: recent progress in the investigation of patients with panic disorder.. Behav Res Ther2014;62:88-94.">Yang 2014</a>). There may be a similar mechanism of action resulting in possible brain changes following psychological therapy in adolescents with psychosis. The underlying premise of CBT is that thoughts and behaviours are related and can be rationally challenged. It may be acceptable to certain young people who are in a stage of life where they are trying to explain their worldly experiences logically. Cognitive remediation therapy and cognitive behavioural therapy aim to improve cognitive and adaptive functioning and maybe particularly suitable in adolescents who may have more neuronal plasticity and are earlier in the course of illness progression. </p> <p>Family is the most important source of support for the young person and it is crucial that the family members understand the nature of the illness. Family therapy helps in aiming to improve the functioning of the family as a whole including that of the young person (<a href="./references#CD009533-bbs2-0160" title="LeffJ , BerkowitzR , ShavitN , StrachanA , GlassI , Vaughn C. A trial of family therapy v. a relatives group for schizophrenia.. Br J Psychiatry1989;154:58-66.">Leff 1989</a>). </p> <p>In group therapy, the 11 therapeutic factors emphasised by Yalom (<a href="./references#CD009533-bbs2-0214" title="YalomID , LeszczM . The theory and practice of group psychotherapy. 5th edition. New York: Basic books, 2005.">Yalom 2005</a>) that influence change and healing include, amongst others, universality (group members realising they are not alone in their problems), altruism (gaining a sense of value by helping other group members), corrective recapitulation (resolution of family and childhood conflicts within the safety of the group family), socialising techniques (learning tolerance, empathy and interpersonal skills), group cohesiveness (developing a sense of acceptance and belonging) and catharsis (releasing suppressed emotions by disclosing information to group members). We have thus classified group therapy separately from individual therapy. </p> <p>Psychological therapies, as part of a broader programme, that focus on vocational training are likely to reduce stigma and help the person to training or employment. Thus psychological interventions for adolescents may act through a number of different mechanisms. </p> </section> <section id="CD009533-sec-0013"> <h3 class="title" id="CD009533-sec-0013">Why it is important to do this review</h3> <p>In the last 20 years, there has been considerable research on psychological interventions for adults with psychosis. As a large proportion of adults with psychotic illnesses have their onset in adolescence, it is crucial to review the evidence of psychological interventions in adolescents. Intervening during adolescence may help to prevent the onset of more serious enduring mental disorders that persist life‐long, reduce acute psychological distress, reduce stigma, reduce high risk behaviours and foster a better therapeutic alliance with mental health services. </p> <p>Schizophrenia is a neurodevelopmental disorder and it is important that any psychological treatments delivered are effective for the target age group, be they children or adults. What works with adults may not do so with children or adolescents. This review aims to evaluate available evidence and gaps in current research on psychological interventions for adolescents with psychosis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009533-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009533-sec-0014"></div> <p>To assess the effects of various psychological interventions for adolescents with psychosis. See <a href="#CD009533-sec-0206">Differences between protocol and review</a>. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009533-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009533-sec-0015"></div> <section id="CD009533-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009533-sec-0017"> <h4 class="title">Types of studies</h4> <p>All relevant randomised controlled trials related to psychological interventions for adolescents with psychosis. If a trial was described as a 'double‐blind' trial but implied randomisation, we included such trials in the sensitivity analysis (see <a href="#CD009533-sec-0083">Sensitivity analysis</a>). If the inclusion of such trials did not result in a substantive difference, they remained in the analyses. However, If including such trials did not result in statistically significant differences, we did not add the data from these lower quality studies to the results of the better trials, but presented such data within a subcategory. Quasi‐randomised studies were excluded, such as those allocating by alternate days of the week. In trials where people are given additional treatments within a psychological intervention trial, data were included only if the adjunct treatment was evenly distributed between groups and only the psychological intervention was randomised. </p> </section> <section id="CD009533-sec-0018"> <h4 class="title">Types of participants</h4> <p>Studies with adolescent participants, aged 13 years to 17 years, with a diagnosis of any form of psychosis including acute psychosis, schizophrenia or related disorders, including schizophreniform disorder, schizoaffective disorder, delusional disorder and affective psychosis were included if they met the criteria set by the review group. In trials that recruited adolescents as well as adults, data for adolescents only were included if found to be available. Complete trial data were used only if 75% or more of the participants were within the age group of 13 to 17 years. The review has excluded studies that were only on prodromal psychosis. However, it included studies that had a mixed group of young people with a variety of psychosis such as affective psychosis, schizophrenia and others. The review was restricted to young people older than 13 years as it is extremely rare for children younger than 13 years of age to develop psychosis and this is covered in a separate review (<a href="./references#CD009533-bbs2-0152" title="KennedyE , KumarA , DattaSS . Antipsychotic medication for childhood-onset schizophrenia. Schizophrenia Bulletin2007;33(5):1082-3.">Kennedy 2007</a>; <a href="./references#CD009533-bbs2-0153" title="KennedyE , KumarA , DattaSS . Antipsychotic medication for childhood-onset schizophrenia. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD004027.pub2]">Kennedy 2007a</a>). </p> </section> <section id="CD009533-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD009533-sec-0020"> <h5 class="title">1. Psychological interventions for adolescents with psychosis</h5> <p>Psychological interventions are defined as any psychological intervention, whether group or individual, aimed at either reducing symptoms or enhancing social and individual functioning. The psychological interventions needed to be standardised and replicable and delivered by trained therapists in a well‐structured care programme. The psychological interventions were categorised as follows: </p> <p>i. Cognitive Remediation Therapy (individual CRT or computer‐assisted CRT)</p> <p>ii. Cognitive Behaviour Therapy (CBT)</p> <p>iii. Family‐based interventions</p> <p>iv. Adherence‐improvement therapy</p> <p>v. Psychoeducation</p> <p>vi. Group therapy of any modality</p> </section> <section id="CD009533-sec-0021"> <h5 class="title">2. The control treatment</h5> <p>(a) Absolute effect of psychological interventions: control treatment was defined as standard care without a dedicated programme of type described above. </p> <p>(b) Relative effect of psychological interventions: some studies used the comparator arm of one of the above modalities of psychological treatments. In other words, they compared one form of psychological treatment with another. </p> </section> </section> <section id="CD009533-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We divided outcomes into short‐term (less than six months), medium‐term (seven to 12 months) and long‐term (more than one year). </p> <section id="CD009533-sec-0023"> <h5 class="title">Primary outcomes</h5> <section id="CD009533-sec-0024"> <h6 class="title">1. Global state</h6> <p>1.1 Clinically important change ‐ as defined by each of the studies<br/>1.2 Relapse </p> </section> <section id="CD009533-sec-0025"> <h6 class="title">2. Mental state</h6> <p>2.1 Clinically important change in psychotic symptoms ‐ as defined by each of the studies </p> <p>2.2 Clinically important change in mood symptoms ‐ as defined by each of the studies</p> </section> <section id="CD009533-sec-0026"> <h6 class="title">3. Cognitive functioning</h6> <p>3.1 Clinically important change ‐ as defined by each of the studies</p> </section> <section id="CD009533-sec-0027"> <h6 class="title">3. Global functioning</h6> <p>3.1 Clinically important change ‐ as defined by each of the studies</p> </section> <section id="CD009533-sec-0028"> <h6 class="title">4. Adverse effects</h6> <p>4.1 Clinically important adverse effects ‐ as defined by each of the studies</p> </section> <section id="CD009533-sec-0029"> <h6 class="title">5. Service use</h6> <p>5.1 Hospital admission ‐ as defined by each of the studies</p> </section> </section> <section id="CD009533-sec-0030"> <h5 class="title">Secondary outcomes</h5> <p><b>1. Global state</b> </p> <p>1.1 Any change in global state ‐ as defined by each of the studies<br/>1.2 Average endpoint/change score on global state scale </p> <p><b>2. Mental state</b> </p> <p>2.1 Any change in mental state ‐ as defined by each of the studies<br/>2.2 Average endpoint/change score on mental state scale </p> <section id="CD009533-sec-0031"> <h6 class="title">3. Cognitive functioning</h6> <p>2.2 Any change in cognitive symptoms ‐ as defined by each of the studies<br/>2.3 Average endpoint/change score on cognitive function scale </p> </section> <section id="CD009533-sec-0032"> <h6 class="title">4. Global functioning</h6> <p>4.1 Any change in global functioning ‐ as defined by each of the studies<br/>4.2 Average endpoint/change score on global functioning scale </p> <p><b>5. Social functioning</b> </p> <p>5.1 Average endpoint/change score on social skills scale<br/>5.2 Educational status/occupational status<br/>5.3 Compliance with (a) drug treatment and (b) other non‐drug treatments </p> <p><b>6. Adverse effects/events</b> </p> <p>6.1 Death, suicide or natural causes<br/>6.2 Attempted suicide, suicidality or self harm<br/>6.4 Incidence of clinically important depression/anxiety<br/>6.5 Change in drug/alcohol use<br/>6.6 General adverse effects<br/>6.7 Specific adverse effects<br/>6.8 Average endpoint or change score on adverse effects scale </p> <p><b>7. Service use</b> </p> <p>7.1 Days in hospital</p> <p><b>8. Economic outcomes</b> </p> <p><b>9. Quality of life/satisfaction with care for either recipients of care or carers</b> </p> <p>9.1 Clinically important change in quality of life/satisfaction ‐ as defined by each of the studies<br/>9.2 General impression of carer/other<br/>9.3 Average endpoint/change score in quality of life/satisfaction </p> </section> <section id="CD009533-sec-0033"> <h6 class="title">10. Leaving the study early</h6> <p>10.1 For any reason<br/>10.2 For specific reason </p> </section> </section> <section id="CD009533-sec-0034"> <h5 class="title">'Summary of findings' table</h5> <p>The GRADE approach was used to interpret findings (<a href="./references#CD009533-bbs2-0192" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.">Schünemann 2008</a>) and we exported data from our review using <a href="http://methods.cochrane.org/gradeing/gradepro-gdt" target="_blank">GRADEpro</a> to create a 'Summary of findings' table for each comparison. These tables provided outcome‐specific information concerning the overall quality of evidence from each of the included studies in the comparison and the magnitude of effect of the interventions examined. We considered the sum of available data on all outcomes were important to patient‐care and decision‐making. We aimed to include the following main outcomes in the 'Summary of findings' table (see <a href="#CD009533-sec-0206">Differences between protocol and review</a>): </p> <p> <ol id="CD009533-list-0001"> <li> <p>Global state: clinically important change ‐ as defined by each of the studies</p> </li> <li> <p>Mental state: clinically important change ‐ as defined by each of the studies</p> </li> <li> <p>Cognitive functioning: clinically important change ‐ as defined by each of the studies</p> </li> <li> <p>Global functioning: clinically important change ‐ as defined by each of the studies</p> </li> <li> <p>Adverse effects: clinically important adverse effect ‐ as defined by each of the studies</p> </li> <li> <p>Service use: hospital admission</p> </li> <li> <p>Leaving the study early ‐ for any reason</p> </li> </ol> </p> <p>If data were not available for our preferred outcomes but available for ones that were similar, we presented the closest outcome to the prespecified one in the table but took this into account when grading the finding. </p> </section> </section> </section> <section id="CD009533-sec-0035"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009533-sec-0036"> <h4 class="title">Electronic searches</h4> <section id="CD009533-sec-0037"> <h5 class="title">Cochrane Schizophrenia Group’s Study‐Based Register of Trials</h5> <p>On 31 May 2016 and 8 March 2019, the information specialist searched the register using the following search strategy: </p> <p>((*Child* OR *Adolescent*) in Participants) AND (*Psychological Intervention* in Intervention) of STUDY </p> <p>In such a study‐based register, searching the major concept retrieves all the synonyms and relevant studies because all the studies have already been organised based on their interventions and linked to the relevant topics (<a href="./references#CD009533-bbs2-0195" title="ShokranehF , AdamsCE . Study-based registers of randomized controlled trials: Starting a systematic review with data extraction or meta-analysis. BioImpacts2017;7(4):209-217. [DOI: 10.15171/bi.2017.25]">Shokraneh 2017</a>). </p> <p>This register is compiled by systematic searches of major resources (AMED, BIOSIS, CENTRAL, CINAHL, ClinicalTrials.Gov, Embase, ISRCTN, MEDLINE, PsycINFO, PubMed, WHO ICTRP) and their monthly updates, ProQuest Dissertations and Theses A&amp;I and its quarterly update, Chinese databases (CBM, CNKI, and Wanfang) and their annual updates, handsearches, grey literature, and conference proceedings (see <a href="http://schizophrenia.cochrane.org/register-trials" target="_blank">Group's website</a>). There is no language, date, document type, or publication status limitations for inclusion of records into the register. </p> <p>For previous searches, please see <a href="./appendices#CD009533-sec-0193">Appendix 1</a>. </p> </section> </section> <section id="CD009533-sec-0038"> <h4 class="title">Searching other resources</h4> <section id="CD009533-sec-0039"> <h5 class="title">1. Reference searching</h5> <p>References of all identified included studies were inspected for further relevant studies. </p> </section> <section id="CD009533-sec-0040"> <h5 class="title">2. Personal contact</h5> <p>The first author of each included study was contacted for further information regarding unpublished trials. </p> </section> </section> </section> <section id="CD009533-sec-0041"> <h3 class="title" id="CD009533-sec-0041">Data collection and analysis</h3> <section id="CD009533-sec-0042"> <h4 class="title">Selection of studies</h4> <p>SD and RD independently inspected citations from the searches and identified relevant abstracts. AK also independently reinspected a random 20% sample to ensure reliability. Full reports of the abstracts meeting the review criteria were obtained. References/abstracts that the review authors disagreed on were further inspected by AK. Again, AK reinspected a random 20% of reports in order to ensure a reliable selection was made. Where it was not possible to resolve disagreements by discussion, reviewers attempted to contact the authors of the study for further clarifications. </p> </section> <section id="CD009533-sec-0043"> <h4 class="title">Data extraction and management</h4> <section id="CD009533-sec-0044"> <h5 class="title">1. Extraction</h5> <p>SD and RD extracted data from all included studies. In addition, to ensure reliability, AK independently extracted data from a random sample of these studies, comprising 10% of the total. Again, any disagreements that arose were discussed, decisions were documented and, if necessary, authors of studies were contacted for clarifications. With remaining problems, AK helped to clarify issues and final decisions were recorded. Wherever possible, data extracted from the trials were presented only in graphs and figures, and were included only if two authors independently reached the same result. Attempts were made to contact authors through open‐ended requests in order to obtain missing information or for clarification, whenever necessary. If studies were multi‐centre trials, where possible, data extraction was carried out relevant to each component centre separately. </p> </section> <section id="CD009533-sec-0045"> <h5 class="title">2. Management</h5> <section id="CD009533-sec-0046"> <h6 class="title">2.1 Forms</h6> <p>Data extraction was done onto standard simple forms.</p> </section> <section id="CD009533-sec-0047"> <h6 class="title">2.2 Scale‐derived data</h6> <p>Continuous data from rating scales were included only if:<br/>a. the psychometric properties of the measuring instrument were described in a peer‐reviewed journal (<a href="./references#CD009533-bbs2-0166" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249-52.">Marshall 2000</a>); and<br/>b. the measuring instrument was not written or modified by one of the trialists for that particular trial. Ideally, the measuring instrument was: i. a self‐report or ii. completed by an independent rater or relative (not the therapist). Since this was not often reported clearly, it has been mentioned in the Description of Studies if this was the case or not. </p> </section> <section id="CD009533-sec-0048"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data. Change data is known to remove a component of between‐person variability from the analysis. On the other hand, calculation of change needed two assessments (baseline and endpoint), which can be difficult in unstable and difficult to measure conditions such as schizophrenia. Primarily in this review, endpoint data have been used, and change data have only been used if the former was unavailable. Endpoint and change data were combined in the analysis as mean differences (MDs) were used rather than standardised mean differences throughout (<a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD009533-sec-0049"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes were often not normally distributed. To avoid the pitfall of applying parametric tests to nonparametric data, reviewers aimed at applying the following standards to all data before inclusion: a) standard deviations and means were reported in the paper or obtained from the authors; b) when the scale started from the finite number zero, the standard deviation, when multiplied by two, was less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution (<a href="./references#CD009533-bbs2-0104" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313(7066):1200.">Altman 1996</a>)); c) if a scale started from a positive value (such as PANSS (Positive and Negative Syndrome Scale) which can have values from 30 to 210), the calculation described above was modified to take the scale starting point into account. In these cases, skew was considered to be present if 2SD &gt; (S ‐ S min), where S is the mean score and S min is the minimum score. Endpoint scores on scales often had a finite start and endpoint and these rules could be applied. When continuous data were presented on a scale that included a possibility of negative values (such as change data), it is difficult to tell whether data are skewed or not. Skewed data from studies were entered for fewer than 200 participants in additional tables rather than into an analysis. Skewed data posed less of a problem for looking at means if the sample size was large, and these we entered these into the syntheses. </p> </section> <section id="CD009533-sec-0050"> <h6 class="title">2.5 Common measure</h6> <p>To facilitate comparison between trials, reviewers converted variables that were reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD009533-sec-0051"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Wherever possible, outcome measures were converted to dichotomous data. This was done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It was assumed that if there was a 50% reduction in a scale‐derived score such as in the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD009533-bbs2-0175" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799-812.">Overall 1962</a>) or the Positive and Negative Syndrome Scale (PANSS, <a href="./references#CD009533-bbs2-0151" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>), this could be considered as a clinically significant response (<a href="./references#CD009533-bbs2-0161" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelRR . What does the PANSS mean?Schizophrenia Research2005;79(2-3):231-8. [PMID: 15982856]">Leucht 2005</a>; <a href="./references#CD009533-bbs2-0162" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry2005;187:366-71. [PMID: 16199797]">Leucht 2005a</a>). If data based on these thresholds were not available, the primary cut‐off presented by the original authors was used. </p> </section> <section id="CD009533-sec-0052"> <h6 class="title">2.7 Direction of graphs</h6> <p>Where possible, data were entered in such a way that the area to the left of the line of no effect indicated a favourable outcome for psychological interventions for psychosis in adolescents. Where keeping to this made it impossible to avoid outcome titles with clumsy double‐negatives (e.g. 'Not improved'), data where the left of the line indicated an unfavourable outcome were reported. This was noted in the relevant graphs. </p> </section> </section> </section> <section id="CD009533-sec-0053"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Again SD and RD worked independently to assess risk of bias by using the criteria described in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) to assess quality of the trials. This set of criteria is based on evidence of associations between an overestimate of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. </p> <p>If raters disagreed, the final rating was made by consensus, with the involvement of another member of the review group (AK). Where inadequate details of randomisation and other characteristics of trials were found, authors of the studies were contacted in order to obtain further information. Nonconcurrence in quality assessment was reported, and if disputes arose as to which category a trial was to be allocated, again, resolution was sought by discussion. </p> <p>The level of risk of bias was noted in both the text of the review and in the 'Summary of findings' table 1. </p> </section> <section id="CD009533-sec-0054"> <h4 class="title">Measures of treatment effect</h4> <section id="CD009533-sec-0055"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI) was calculated. It has been shown that RR is more intuitive (<a href="./references#CD009533-bbs2-0116" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , BoutitieF , NonyP , HaughM , MignotG . The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie1999;54(4):405-11. [PMID: 10667106]">Boissel 1999</a>) than odds ratios and that odds ratios tend to be interpreted as RRs by clinicians (<a href="./references#CD009533-bbs2-0119" title="DeeksJ . Issues in the selection for meta-analyses of binary data. In: Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town. Cape Town: The Cochrane Collaboration, 2000.">Deeks 2000</a>). </p> </section> <section id="CD009533-sec-0056"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, mean difference (MD) between groups was estimated. Reviewers preferred not to calculate the effect size measures of standardised mean difference (SMD). However, if scales of very considerable similarity were found to be used, it was presumed that there was a small difference in measurement, and effect size was calculated and transformed back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD009533-sec-0057"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009533-sec-0058"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice) but analysis and pooling of clustered data pose problems. Firstly, authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD009533-bbs2-0121" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7(6):623-9.">Divine 1992</a>) whereby P values are spuriously low and CIs with unduly narrow and statistical significance are overestimated. This causes type I errors (<a href="./references#CD009533-bbs2-0115" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315:600.">Bland 1997</a>; <a href="./references#CD009533-bbs2-0140" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876-83.">Gulliford 1999</a>). </p> <p>Where clustering is not accounted for in primary studies, we planned to present data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, we will seek to contact first authors of studies to obtain intra‐class correlation coefficients for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD009533-bbs2-0140" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876-83.">Gulliford 1999</a>). Where clustering has been incorporated into the analysis of primary studies, we planned to present these data as if from a non‐cluster‐randomised study, but adjust for the clustering effect. </p> <p>Reviewers sought statistical advice and were advised that the binary data as presented in a report was to be divided by a 'design effect'. This was calculated using the mean number of participants per cluster (m) and the intra‐class correlation coefficient (ICC) [Design effect = 1 + (m ‐ 1) * ICC] (<a href="./references#CD009533-bbs2-0122" title="DonnerA , KlarN . Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine2002;21(19):2971-80.">Donner 2002</a>). If the ICC was not reported, it was assumed to be 0.1 (<a href="./references#CD009533-bbs2-0203" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPG . Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):iii-92.">Ukoumunne 1999</a>). If cluster studies were appropriately analysed, taking into account intra‐class correlation coefficients and relevant data documented in the report, synthesis with other studies was possible using the generic inverse variance technique. </p> </section> <section id="CD009533-sec-0059"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials was the carry‐over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase of a trail is carried over to the second phase of the trial. As a consequence, on entry into the second phase, the participants may differ systematically from their initial state despite a wash‐out phase. For the same reason, cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD009533-bbs2-0125" title="ElbourneD , AltmanDG , HigginsJPT , CurtinaF , WorthingtondHV , VaileA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9.">Elbourne 2002</a>). As both effects are very likely in severe mental illness, only data of the first phase of cross‐over studies was used in this review. </p> </section> <section id="CD009533-sec-0060"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involved more than two treatment arms, if relevant, additional treatment arms in comparisons were presented. If data were binary, they were simply added and combined within a two‐by‐two table. If data were continuous data, they were combined following the formula in section 7.7.3.8  (Combining groups) of the <i>Handbook</i>. Where the additional treatment arms were found to be not relevant, these data were not reproduced. </p> </section> </section> <section id="CD009533-sec-0061"> <h4 class="title">Dealing with missing data</h4> <section id="CD009533-sec-0062"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up, data must lose credibility (<a href="./references#CD009533-bbs2-0213" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El-SayehH , PinfoldV , TakritiY . Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254-7.">Xia 2009</a>). Reviewers chose that, for any particular outcome, should more than 50% of data be unaccounted for, these data were not reproduced or used within the analyses, except for the outcome of leaving the study early. If, however, more than 50% of those in one arm of a study were lost, but the total loss was less than 50%, such data were marked with (*) to indicate that such a result may well be prone to bias. </p> </section> <section id="CD009533-sec-0063"> <h5 class="title">2. Binary</h5> <p>In the case where attrition for a binary outcome was between 0 and 50% and where these data were not clearly described, data were presented on a 'once‐randomised‐always‐analysed' basis (an intention‐to‐treat analysis). Those who left the study early were all assumed to have the same rates of negative outcome as those who completed, with the exception of the outcome of death and other adverse effects. For those outcomes, the rate of those who stayed in the study ‐ in that particular arm of the trial ‐ was used for those who did not. We undertook a sensitivity analysis to test how prone the primary outcomes were to change when 'completer' data only were compared to the intention‐to‐treat analysis using the above assumptions. </p> </section> <section id="CD009533-sec-0064"> <h5 class="title">3. Continuous</h5> <section id="CD009533-sec-0065"> <h6 class="title">3.1 Attrition</h6> <p>In the case where attrition for a continuous outcome was between 0 and 50% and completer‐only data were reported, data were reproduced. </p> </section> <section id="CD009533-sec-0066"> <h6 class="title">3.2 Standard deviations</h6> <p>If the standard deviations were not reported, reviewers first tried to obtain the missing values from the authors. If not available, where there were missing measures of variance for continuous data, but an exact standard error and confidence intervals were available for group means, and either the P value or T value was available for differences in the mean, it was calculated according to the rules described in the <i>Handbook</i> (<a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). When only the standard error (SE) was reported, standard deviations (SDs) were calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <i>Handbook</i> (<a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) present detailed formula for estimating SDs from P values, T or F values, confidence intervals, ranges or other statistics. If these formulas did not apply, we calculated the SDs according to a validated imputation method which was based on the SDs of the other included studies (<a href="./references#CD009533-bbs2-0129" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7-10.">Furukawa 2006</a>). Although some of these imputation strategies can introduce error, the alternative was to exclude a given study’s outcome and thus to lose information. Nevertheless, the validity of the imputations was examined in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD009533-sec-0067"> <h6 class="title">3.3 Last observation carried forward</h6> <p>Reviewers anticipated that, in some studies, the method of last‐observation‐carried‐forward (LOCF) would be employed within the study report. As with all methods of imputation to deal with missing data, LOCF introduces uncertainty about the reliability of the results (<a href="./references#CD009533-bbs2-0163" title="LeuchtS , EngelRR , BaumlJ , DavisJM . Is the superior efficacy of new generation antipsychotics an artifact of LOCF?Schizophrenia Bulletin2007;33(1):183-91. [PMID: 16905632]">Leucht 2007</a>). Therefore, where LOCF data were used in the trial, if fewer than 50% of the data were assumed, these data were reproduced and it was indicated that they were the product of LOCF assumptions. </p> </section> </section> </section> <section id="CD009533-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD009533-sec-0069"> <h5 class="title">1. Clinical heterogeneity</h5> <p>All included studies were initially taken into consideration, without seeing comparison data, to judge clinical heterogeneity. All studies were simply inspected for clearly outlying people or situations which were not predicted would arise. When such situations or participant groups arose, these were fully discussed. </p> </section> <section id="CD009533-sec-0070"> <h5 class="title">2. Methodological heterogeneity</h5> <p>All included studies were initially taken into consideration, without seeing comparison data, to judge methodological heterogeneity. All studies were simply inspected for clearly outlying people or situations which were not predicted would arise. When such methodological outliers arose, these were fully discussed. </p> </section> <section id="CD009533-sec-0071"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD009533-sec-0072"> <h6 class="title">3.1 Visual inspection</h6> <p>Graphs were visually inspected to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD009533-sec-0073"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>Heterogeneity between studies was investigated by considering the I<sup>2</sup> method alongside the Chi<sup>2</sup> P value. The I<sup>2</sup> provided an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD009533-bbs2-0146" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on: i. magnitude and direction of effects and ii. strength of evidence for heterogeneity (e.g. P value from Chi<sup>2</sup>  test, or a confidence interval for I<sup>2</sup>). An I<sup>2</sup> estimate which was greater than or equal to around 50% accompanied by a statistically significant Chi<sup>2</sup> statistic, was interpreted as evidence of substantial levels of heterogeneity (Section 9.5.2 ‐ <a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). When substantial levels of heterogeneity were found for the primary outcome, reasons for heterogeneity were explored (<a href="#CD009533-sec-0078">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD009533-sec-0074"> <h4 class="title">Assessment of reporting biases</h4> <section id="CD009533-sec-0075"> <h5 class="title">1. Protocol versus full study</h5> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results. These are described in section 10.1 of the <i>Handbook</i> (<a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Reviewers attempted to locate protocols of included randomised trials. If the protocol was available, outcomes in the protocol and in the published report were compared. If the protocol was not available, outcomes listed in the methods section of the trial report were compared with actually reported outcome results. </p> </section> <section id="CD009533-sec-0076"> <h5 class="title">2. Funnel plot</h5> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD009533-bbs2-0124" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>). These are described in Section 10 of the <i>Handbook</i> (<a href="./references#CD009533-bbs2-0147" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Reviewers were aware that funnel plots may be useful in investigating reporting biases but they are of limited power to detect small‐study effects. Funnel plots for outcomes where there were ten or fewer studies, or where all studies were of similar sizes were therefore not used. In other cases, where funnel plots were possible, statistical advice in their interpretation was sought. </p> </section> </section> <section id="CD009533-sec-0077"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies were estimating different, yet related, intervention effects. This often seemed to be true to us and the random‐effects model took into account differences between studies even if there was no statistically significant heterogeneity. There was, however, a disadvantage to the random‐effects model: it put added weight onto small studies which often were the most biased ones. Depending on the direction of effect, these studies could either inflate or deflate the effect size. Reviewers chose random‐effects model for all analyses. The reader is, however, able to choose to inspect the data using the fixed‐effects model. </p> </section> <section id="CD009533-sec-0078"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD009533-sec-0079"> <h5 class="title">1. Subgroup analyses ‐ only primary outcomes</h5> <section id="CD009533-sec-0080"> <h6 class="title">1.1 Cognitive remediation therapy versus standard care</h6> <p>Subgroup analyses investigating 'cognitive remediation therapy' and standard care were anticipated. We had undertaken to analyse the data for this comparison and have presented it in the Results section. </p> </section> <section id="CD009533-sec-0081"> <h6 class="title">1.2 Clinical state, stage or problem</h6> <p>We had proposed to undertake this review and provide an overview of the effects of psychological interventions for adolescents with psychosis. In addition, however, if there were data on subgroups of people in the same clinical state, stage and with similar problems, we would have reported this separately. Only one study (<a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>) had provided some information on the stage of illness but the data were too sparse to be used meaningfully. </p> </section> </section> <section id="CD009533-sec-0082"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>If inconsistency was found to be high, it was reported. First, reviewers investigated whether data were correctly reported. Second, if data were correct, the graphs were visually inspected and studies were successively removed outside of the company of the rest to see if heterogeneity was restored. For this review, it was decided that should this occur with data contributing to the summary finding of no more than around 10% of the total weighting, data would be presented. If not, data were not pooled and issues were discussed. We know of no supporting research for this 10% cut‐off but are investigating use of prediction intervals as an alternative to this unsatisfactory state. When unanticipated clinical or methodological heterogeneity was obvious, the hypotheses regarding this for future reviews or versions of this review were simply stated. Reviewers did not anticipate undertaking analyses relating to these. </p> </section> </section> <section id="CD009533-sec-0083"> <h4 class="title">Sensitivity analysis</h4> <section id="CD009533-sec-0084"> <h5 class="title">1. Implication of randomisation</h5> <p>Reviewers aimed to include trials in a sensitivity analysis if they were described in some way as to imply randomisation. For the primary outcomes, these studies were included and if there was no substantive difference when the implied randomised studies were added to those with better description of randomisation, then all data from these studies were employed. </p> </section> <section id="CD009533-sec-0085"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD009533-sec-0061">Dealing with missing data</a>), the findings of the primary outcomes were compared when we used our assumption compared with completer data only. If there was a substantial difference, it was reported and discussed, but reviewers continued to employ the assumption. </p> <p>Where assumptions had to be made regarding missing SD data (see <a href="#CD009533-sec-0061">Dealing with missing data</a>), findings on primary outcomes were compared when reviewers used the assumption compared with complete data only. A sensitivity analysis was undertaken testing how prone results were to change when 'completer' data only were compared to the imputed data using the above assumption. If there was a substantial difference, it was reported and discussed, but reviewers continued to employ the assumption. </p> </section> <section id="CD009533-sec-0086"> <h5 class="title">3. Risk of bias</h5> <p>Reviewers analysed the effects of excluding trials that were judged to be at high risk of bias across one or more of the domains of randomisation (implied as randomised with no further details available), allocation concealment, blinding and outcome reporting for the meta‐analysis of the primary outcome. If the exclusion of trials at high risk of bias did not substantially alter the direction of effect or the precision of the effect estimates, data from these trials were included in the analysis. </p> </section> <section id="CD009533-sec-0087"> <h5 class="title">4. Imputed values</h5> <p>A sensitivity analysis was undertaken to assess the effects of including data from trials where imputed values for ICC were used in calculating the design effect in cluster‐randomised trials. </p> <p>If substantial differences were noted in the direction or precision of effect estimates in any of the sensitivity analyses listed above, the data were not pooled from the excluded trials with the other trials contributing to the outcome, but were presented separately. </p> </section> <section id="CD009533-sec-0088"> <h5 class="title">5. Fixed‐effect and random‐effects</h5> <p>All data were synthesised using a random‐effects model; however, reviewers also synthesised data for the primary outcome using a fixed‐effect model to evaluate whether the greater weights assigned to larger trials with greater event rates altered the significance of the results compared to the more evenly distributed weights in the random‐effects model. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009533-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009533-sec-0089"></div> <section id="CD009533-sec-0090"> <h3 class="title">Description of studies</h3> <p>For detailed description of included studies, excluded studies and those that are ongoing studies please see: <a href="./references#CD009533-sec-0210" title="">Characteristics of included studies</a>; <a href="./references#CD009533-sec-0211" title="">Characteristics of excluded studies</a>; <a href="./references#CD009533-sec-0213" title="">Characteristics of ongoing studies</a>. </p> <section id="CD009533-sec-0091"> <h4 class="title">Results of the search</h4> <p>The systematic search identified 3573 references. Duplicates were scrutinised and removed. There were 3483 unique reports. The 3483 reports were screened for inclusion by reviewing the titles and abstracts, and 3279 records were excluded. Two hundred and four full‐text articles were reviewed for eligibility. There were 13 ongoing studies that will be considered for future versions of this review. Seven studies, with 27 references, fulfilled our predetermined inclusion criteria and were included in the quantitative meta‐analysis. The results of the search are shown in the PRISMA table (<a href="#CD009533-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD009533-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009533-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009533-sec-0092"> <h4 class="title">Included studies</h4> <p>Seven studies met the inclusion criteria (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>; <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>; <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>; <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>; <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>; <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>; <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>). <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> published medium‐term data of a follow‐up duration of one year that were included in the analysis. <a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a> had longer term follow‐up data published separately. The data from the longer term two‐year follow‐up <a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a> were included in the analysis. </p> <section id="CD009533-sec-0093"> <h5 class="title">1. Length of trials</h5> <section id="CD009533-sec-0094"> <h6 class="title">1.1. Short‐term (up to six months)</h6> <p>Five of the seven studies reported short‐term outcomes (up to six months). <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a> reported data for up to six weeks, <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a> reported data up to eight weeks. <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>; <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> reported data up to three months. </p> </section> <section id="CD009533-sec-0095"> <h6 class="title">1.2 Medium‐term (six months to one year)</h6> <p>Medium‐term follow‐up (six months to one year) data were reported by <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> (26 weeks) and <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> (one year). </p> </section> <section id="CD009533-sec-0096"> <h6 class="title">1.3 Long‐term (more than one year)</h6> <p>The study conducted by <a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a> published data for a two‐year follow‐up and data from this publication were included in this review. </p> </section> </section> <section id="CD009533-sec-0097"> <h5 class="title">2. Participants</h5> <p>Five studies (<a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>; <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>; <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>; <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>; <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>) included young people with psyhosis or schizophrenia as defined by clear operational criteria. One of the studies (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>) included adolescents with schizophrenia and affective psychosis. <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a> included young people with diagnosed psychotic illnesses such as schizophrenia, schizoaffective disorder, schizotypal disorder as well as those who were at high risk of psychosis. </p> <p>There were 319 adolescent participants in total for the seven included studies. All studies clearly reported the gender of the trial participants. Most participants were aged between 13 and 17 years. All the studies randomised fewer than 100 participants each. </p> </section> <section id="CD009533-sec-0098"> <h5 class="title">3. Setting</h5> <p>Three of the studies were conducted in inpatient settings (<a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>; <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>; <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>). Four of the studies were conducted exclusively in the outpatient setting (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>; <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>; <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>, <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>). The studies were conducted in China (<a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>), Norway (<a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>), the United Kingdom (<a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>), Spain (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>; <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>), Switzerland (<a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>), and Russia (<a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>). All the studies were conduted in a single centre. All seven studies were published in the period between 2004 (<a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>) and 2016 (<a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>). </p> </section> <section id="CD009533-sec-0099"> <h5 class="title">5. Interventions</h5> <section id="CD009533-sec-0100"> <h6 class="title">5.1 Psychological Interventions</h6> <p> <ul id="CD009533-list-0002"> <li> <p>Cognitive Remediation therapy: individual (CRT) or computer‐assisted (CACRT)</p> </li> </ul> </p> <p><a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> compared a cognitive remediation programme (CRP) and psychoeducational treatment programme (PTP) compared to the PTP only. Central elements of the PTP were parent seminars, problem‐solving sessions, milieu therapy and network groups. The CRP group received 30 hours of individual training consisting of four modules: cognitive differentiation, attention, memory and social perception. <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> compared cognitive remediation therapy (CRT) given thrice a week in 40 one hourly sessions and treatment‐as‐usual, compared with treatment‐as‐usual. In each session of CRT, a variety of tasks were presented to practice the component processes in remembering, complex planning and problem solving. <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> compared cognitive remediation with treatment‐as‐usual (TAU). Computer‐assisted cognitive remediation were compared to non‐therapeutic computer games in the study by <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>. </p> <p> <ul id="CD009533-list-0003"> <li> <p>Group psychosocial therapy (GPT)</p> </li> </ul> </p> <p>Basal training of communication skills based on a psychoeducational approach with elements of motivational training, training to cope with residual symptoms of illness, along with the use during treatment of art therapy methods directed to developing communication skills was used in <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> </p> <p> <ul id="CD009533-list-0004"> <li> <p>Nonstructured group therapy (NSGT)</p> </li> </ul> </p> <p>This included problem‐solving and crisis management; the facilitators did not follow a pre‐set model but used a supportive group approach that connected persons facing similar challenges, thus enabling members to share experiences and advice (for example, on medication and side effects). During nonstructured intervention, no written material was provided to parents or adolescents. </p> <p> <ul id="CD009533-list-0005"> <li> <p>Psychoeducation + multi‐family treatment</p> </li> </ul> </p> <p>Adolescents and parents received group psychoeducational interventions separately. Adolescent participants received 12 sessions of group psychoeducational interventions of 90 minutes each session, conducted every 15 days. One or both parents of the adolescents also received a group psychoeducational intervention for parents lasting 90 minutes, every 15 days. Both contents and group structure were the same in the adolescents and parents’ version of the group treatment. Groups specifically focussed on problem‐solving strategies to manage daily life situations associated with the disease to manage crises and to prevent relapses of psychosis. At the end of each group session, participants were encouraged to put the skills learnt in actual practice. </p> <p> <ul id="CD009533-list-0006"> <li> <p>Structural group therapy (SGT)</p> </li> </ul> </p> <p>The intervention consisted of a 12‐session group therapy activity intervention programme. This was used by <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>. Each session lasted 1 hour, with different themes and types of activities and was held twice a week for six weeks. The content of the group activity was varied e.g. centred around engaging with the group, improving self awareness, expressing and accepting likes and dislikes of others, helping one to express emotions effectively, becoming aware of one's strengths and self concepts, rebuilding self cognitions, addressing stigma of the disease and becoming aware of changes one has undergone over time. </p> </section> <section id="CD009533-sec-0101"> <h6 class="title">5.2 Control interventions</h6> <p> <ul id="CD009533-list-0007"> <li> <p>Computer Games</p> </li> </ul> </p> <p>A set of video games that require attention and visuomotor skills was used as a control intervention by <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>. The participants of the computer games group received once a week a 2.5 hours of session of video games over eight weeks. </p> <p> <ul id="CD009533-list-0008"> <li> <p>Handicraft Activities</p> </li> </ul> </p> <p>The control group that was part of <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a> included a handicraft group, twice a week over six weeks. The details of the activities have not been described in detail by the authors. </p> <p> <ul id="CD009533-list-0009"> <li> <p>Treatment‐as‐usual: where participants continued their normal care. Treatment‐as‐usual was the comparator for <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>, <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, and <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>. </p> </li> </ul> </p> </section> </section> <section id="CD009533-sec-0102"> <h5 class="title">6. Outcomes</h5> <p>Listed below are scales used in the trials where usable data could be obtained:</p> <section id="CD009533-sec-0103"> <h6 class="title">6.1 Global state scales</h6> <p> <ul id="CD009533-list-0010"> <li> <p>Global Assessment Scale (GAS, <a href="./references#CD009533-bbs2-0126" title="EndicottJ , SpitzerRL , FleissJL , CohenJ . The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry1976;33:766-71.">Endicott 1976</a>) </p> </li> </ul> </p> <p>The Global Assessment Scale (GAS) was reported by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. This scale rates psychological or psychiatric health on a scale ranging from 0 to 100. </p> <p> <ul id="CD009533-list-0011"> <li> <p>Children's Global Assessment Scale (CGAS, <a href="./references#CD009533-bbs2-0193" title="ShafferD , GouldMS , BrasicJ , AmbrosiniP , FisherP , BirdH , et al. A children's global assessment scale (CGAS). Archives of general psychiatry1983;40(11):1228-31. [PMID: 6639293]">Shaffer 1983</a>) </p> </li> </ul> </p> <p>The Children's Global Assessment Scale (C‐GAS) was used in three studies (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>; <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>; <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>). No usable data from this scale was reported by <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>. The C‐GAS is used to rate the global mental state of children and adolescents on a single point rating from 1 (very poor) to 100 (no problem) based on the child's emotional and behavioural difficulties, usually over a period of the preceding three months. </p> <p> <ul id="CD009533-list-0012"> <li> <p>Health of Nation Outcome Scale for Children and Adolescents (HoNOSCA) (<a href="./references#CD009533-bbs2-0138" title="GowersSG , HarringtonRC , WhittonA , LelliotP , BeevorA , WingJ , et al. Brief scale for measuring the outcomes of emotional and behavioural disorders in children. Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). British Journal of Psychiatry1999;174:413-416.">Gowers 1999</a>) </p> </li> </ul> </p> <p>The HoNOSCA was reported by <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>. This scale was developed to rate the outcome of children and adolescents with mental health difficulties who were aged three to 18 years. The scale has 13 clinical items and each item is rated on a 5‐point severity scale, with higher scores indicating more problems. On repeat administration, a change score can also be calculated, with two additional items. </p> </section> <section id="CD009533-sec-0104"> <h6 class="title">6.2 Mental state scales</h6> <p> <ul id="CD009533-list-0013"> <li> <p>Brief Psychiatric Rating Scale (BPRS) (<a href="./references#CD009533-bbs2-0175" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799-812.">Overall 1962</a>) </p> </li> </ul> </p> <p>This is a clinician‐rated 16‐item scale that assesses major psychiatric symptoms. Each item is scored on a 7‐point scale ranging from 1 (not present) to 7 (extremely severe). The range of scores possible for the 18‐item standard scale is between 18 and 126, high scores indicating more severe symptoms. There is an expanded version of the BPRS scale which has 24 items and the maximum score possible is 168. The BPRS was used by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> <p> <ul id="CD009533-list-0014"> <li> <p>Positive And Negative Symdrome Scale (PANSS) (<a href="./references#CD009533-bbs2-0151" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>) </p> </li> </ul> </p> <p>The PANSS assesses psychotic symptomatology and has three subscales; positive symptoms (7 items), negative symptoms (7 items) and general psychopathology (16 items). Each item is rated on a 7‐point scale ranging from 1 (absent) to 7 (extreme). There is also a total score generated by the scale. Since the lowest score for each item is 1, the minimum total score for anyone rated on PANSS is 30. The PANSS was used by <a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>, <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>, <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>, <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, and <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>. </p> <p> <ul id="CD009533-list-0015"> <li> <p>Child Behaviour Checklist (CBCL, <a href="./references#CD009533-bbs2-0102" title="AchenbachTM . Manual for the Child Behaviour Checklist/4-18 and 1991 profile. Burlington: University of Vermont, 1991.">Achenbach 1991</a>) </p> </li> </ul> </p> <p>CBCL is a 118‐item parent‐ or teacher‐rated instrument to quantify psychopathology in children aged six to 18 years. The CBCL generates an internalising, externalising and total psychopathology score, in addition to several subscale scores. This scale was reported by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> </section> <section id="CD009533-sec-0105"> <h6 class="title">6.3 Cognitive functioning scales</h6> <p> <ul id="CD009533-list-0016"> <li> <p>Backward Masking Test (BMT<i>)</i> (<a href="./references#CD009533-bbs2-0188" title="RundBR , OieM , SundetK . Backward masking deficit in adolescents with schizophrenic disorders or attention deficit hyperactivity disorder. Am J Psychiatry1996;153:1154-1157.">Rund 1996</a>) </p> </li> </ul> </p> <p>The BMT is a cognitive task which is used to assess pre‐attentional processing and the earliest phases of visual information processing. The task consists of 30 stimulus presentations where 10 are presented with no mask, 10 with a 33.0 ms stimulus onset mask, and the last 10 with a 49.5 ms stimulus onset mask. The maximum possible score in each condition is 20, as identification of each digit in the pair is scored separately. The BMT was used by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> <p> <ul id="CD009533-list-0017"> <li> <p>Span of Apprehension Task (SPAN‐12, <a href="./references#CD009533-bbs2-0109" title="AsarnowRF , NuechterleinKH . Manual and computerprogram for the forced-choice, partial report Span ofApprehension Test (version 3.4).. Los Angeles, CA: UCLA, 1992.">Asarnow 1992</a>) </p> </li> </ul> </p> <p>The SPAN measures early visual information processing. Subjects are presented with sets of three to 12 letters that are flashed for 83 ms. They are then asked to identify target letters from a sequence of letters shown to them. One hundred and twenty‐eight trials are presented with 64 in each array size. This instrument was used by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> <p> <ul id="CD009533-list-0018"> <li> <p>Wisconson Card Sorting Test (WCST, <a href="./references#CD009533-bbs2-0144" title="HeatonRK , CheluneGJ , TalleyJL , KayGG , Curtiss G. Wisconsin Card Sorting Test. Revised and expanded. Odessa: Fla: Psychological Assessment Resources, 1993.">Heaton 1993</a>) </p> </li> </ul> </p> <p>The WCST is a neuropsychological test to assess the ability to display flexibility in changing schedules of reinforcement also known as 'set shifting'. Patients are required to match cards but are not given information on how to do so. The test warrants the use of several cognitive functions such as attention, working memory and visuospatial processing. The WCST was used by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>, and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>. </p> <p> <ul id="CD009533-list-0019"> <li> <p>Kimura recurring figures test (<a href="./references#CD009533-bbs2-0154" title="KimuraD . Right temporal lobe damage. Archives of Neurology1963;8:264-271.">Kimura 1963</a>). </p> </li> </ul> </p> <p>The Kimura recurring figures test is used to assess sustained visual attention. First, the subject is shown 20 stimulus cards with geometric or 'nonsense' figures presented in succession. Then 100 cards are shown for three seconds each. Among the 60 distracter cards, eight of the original cards are randomly interspersed five times and the subject is instructed to indicate whether the card has been seen previously. A perfect performance yields a score of 40 on the test. This instrument was used by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> <p> <ul id="CD009533-list-0020"> <li> <p>Trail Making Test (TMT) (<a href="./references#CD009533-bbs2-0201" title="TombaughTM . Trail making test A and B: normative data stratified by age and education. Arch Clin Neuropsychol2004;2:203-14.">Tombaugh 2004</a>) </p> </li> </ul> </p> <p>The TMT is a neuropsychological test of visual attention and task switching. It consists of two parts. Part A includes 25 targets which are numbered, while part B is shorter and consists of 15 targets which are arranged using alternative numbers and letters (A, 1, B, 2 etc). Individuals are required to connect numbered dots as quickly as possible while maintaining accuracy. The test thus provides information about cognitive abilities such as visual search speed, scanning, processing speed with mental flexibility assessed by part A and executive functions assessed by part B. This instrument was used by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> <p> <ul id="CD009533-list-0021"> <li> <p>Digit Span Test part of WAIS III (<a href="./references#CD009533-bbs2-0209" title="WeschlerD . The Weschler Memory Scale. San Antonio, TX: Psychological Corporation, 1997.">Weschler 1997</a>) </p> </li> </ul> </p> <p>The Digit Span Test is used to measure attention and concentration. Progressively increasing number of digits (starting from one) are told to the patient by the interviewer with specific instructions to remember and relay them back. The greater the number of digits the person is able to remember, the better the score is. The digit span test was reported by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>. </p> <p> <ul id="CD009533-list-0022"> <li> <p>Modified 6 elements test (<a href="./references#CD009533-bbs2-0194" title="ShalliceT , Burgess PW. Deficits in strategy application following frontal lobe damage in man. Brain1991;114:727-41.">Shallice 1991</a>) </p> </li> </ul> </p> <p>In the modified six elements test, participants perform three tasks, each of which have two sections. This test was reported by <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>. </p> <p> <ul id="CD009533-list-0023"> <li> <p>Weschler Memory Scale III (WMS III, <a href="./references#CD009533-bbs2-0209" title="WeschlerD . The Weschler Memory Scale. San Antonio, TX: Psychological Corporation, 1997.">Weschler 1997</a>) </p> </li> </ul> </p> <p>The WMS III is a neuropsychological test that uses both visual and auditory stimuli to measure various memory and attention functions in individuals aged 16 to 89 years. The WMS has eight primary indexes, auditory Immediate, visual Immediate, immediate memory, auditory delayed, visual delayed, auditory reception delayed, general memory, and working memory. It also consists of four supplemental auditory process composites. The WMS III was used by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>. </p> <p> <ul id="CD009533-list-0024"> <li> <p>Rey Auditory Verbal Learning Test (RAVLT, <a href="./references#CD009533-bbs2-0190" title="SchmidtM . Rey Auditory Verbal Learning Test: A Handbook. Los Angeles: Western Psychological Services, 1996.">Schmidt 1996</a>) </p> </li> </ul> </p> <p>The RAVLT was used by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> to assess verbal memory in patients. The test can be used for people aged 16 years and older. </p> <p> <ul id="CD009533-list-0025"> <li> <p>Weschler Intelligence Scale for Children IV (WISC IV, <a href="./references#CD009533-bbs2-0211" title="WeschlerD . The Weschler Intelligence Scale for Children (WISC-IV). Madrid: TEA Ediciones, 2003.">Weschler 2003</a>) </p> </li> </ul> </p> <p>The WISC IV is a paper and pencil or web‐based tool used to measure a child's intellectual ability. It can be administered to children between the ages of six and 16 years.The tool generates a full scale IQ which is representative of the child's general intellectual ability along with five primary index scores. The five primary index scores represent various abilities in discrete cognitive domains and are verbal comprehension index, visual spatial index, fluid reasoning index, working memory index, and processing speed index. The WISC IV was used by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>. </p> <p> <ul id="CD009533-list-0026"> <li> <p>Weschler Adult Intelligence Scale III (WAIS III) <a href="./references#CD009533-bbs2-0210" title="WeschlerD . Escala de Inteligencia para Adultos III. 2nd edition. Madrid: TEA Ediciones, 2001.">Weschler 2001</a> </p> </li> </ul> </p> <p>The WAIS III is an IQ test used to assess intelligence and cognitive ability in individuals aged 16 to 89 years. The test consists of 14 subtests, each of which increases in complexity and difficulty. The tool provides scores for verbal IQ, performance IQ, and full scale IQ, along with four secondary indices, namely, verbal comprehension, working memory, perceptual organisation, and processing speed. The WAIS III was used by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>. </p> <p> <ul id="CD009533-list-0027"> <li> <p>Controlled Oral Word Association Test (COWAT) (<a href="./references#CD009533-bbs2-0114" title="BentonA , HamsherK . Multiphasic Aphasia Examination Manual. Iowa City: University of Iowa, 1978.">Benton 1978</a>) </p> </li> </ul> </p> <p>The COWAT tests verbal fluency and is a subtest of the Multilingual Aphasia Examination (MAE; Benton, Hamsher, &amp; Sivan, 1994). The COWAT is also part of the Halstead Reitan Neuropsychological Battery. The COWAT was used by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>. </p> <p> <ul id="CD009533-list-0028"> <li> <p>Repeatable Battery for Assessment of Neuropsychological States (RBANS) (<a href="./references#CD009533-bbs2-0183" title="RandolphC , TierneyMC , MohrE , ChaseTN . The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of clinical and experimental neuropsychology1998;20(3):310-9. [PMID: 9845158]">Randolph 1998</a>) </p> </li> </ul> </p> <p>The RBANS tests immediate memory and consists of ten subtests for visuospatial/constructional, language, attention, delayed memory, amongst other cognitive constructs. The RBANS was used by <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>. </p> <p> <ul id="CD009533-list-0029"> <li> <p>Degraded Stimulus Continuous Performance Test (CPT, <a href="./references#CD009533-bbs2-0174" title="Degraded Stimulus Continuous Performance Test (DS-CPT) Program for PCs, Windows Version. NuechterleinKH , AsarnowRF . Los Angeles: Authors, 2006.">Nuechterlein 2006</a>) </p> </li> </ul> </p> <p>The CPT is a measure of sustained visual attention. wherein participants are required to press a button every time they saw the 'target' number. Along with the 'target' number, several other single digit numbers were presented to serve as noise trials while all stimulus presentations were degraded. The CPT was used by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. </p> <p> <ul id="CD009533-list-0030"> <li> <p>Landro Verbal Learning Paradigm (<a href="./references#CD009533-bbs2-0159" title="LandrøNI , Ueland T. Verbal memory and verbal fluency in adolescents with schizophrenia spectrum disorders. Psychiatry and Clinical Neurosciences2008;62(6):653-61.">Landro 2008</a>) </p> </li> </ul> </p> <p>The Verbal Learning Paradigm is a tool used to assess verbal learning and long‐term verbal memory. The test consists of a 12‐word list and the key variable for verbal learning is the total number of correct responses across eight trials (maximum possible score is 96). For the items that are not retrieved, selective reminders are provided. To assess long‐term verbal memory, the key measure is the number of items recalled after one hour of presentation (maximum possible score 12). <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> used the Verbal Learning Paradigm. </p> </section> <section id="CD009533-sec-0106"> <h6 class="title">6.4 Global functioning scales</h6> <p> <ul id="CD009533-list-0031"> <li> <p>Vineland Adaptive Behaviour Scale (VABS, <a href="./references#CD009533-bbs2-0197" title="SparrowSS , CicchettiDV , BallaA . Vineland Adaptive Behaviour Scales. Circles Pines: American Guidance Service, 2005.">Sparrow 2005</a>) </p> </li> </ul> </p> <p>The VABS assesses daily functioning and adaptive behaviour. Adaptive behaviours are everyday living skills like getting dressed, going to school, cleaning the house, etc. The expanded interview form of VABS can be used from 0 to 90 years of age. The subscale domains for which specific scores and indices can be calculated on VABS are communication, daily living skills, socialisation, motor skills and a maladaptive behaviour index. The scores are expressed in terms of standard scores, percentile ranks, adaptive levels and age equivalents. VABS scores were reported by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>.. </p> <p> <ul id="CD009533-list-0032"> <li> <p>Social and Occupational Functioning Assessment Scale (SOFAS, <a href="./references#CD009533-bbs2-0106" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th edition. Washington DC: APA, 1994.">APA 1994</a>) </p> </li> </ul> </p> <p>The SOFAS is a measure of an individual's social and occupational functioning. The total score ranges from 1 to 100 and a score of 0 is used to denote inadequate information. The score is not directly influenced by the individual's psychiatric symptoms and takes into account impairment in functioning due to general medical causes and mental disorders. The SOFAS was used by <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>. </p> <p> <ul id="CD009533-list-0033"> <li> <p>Life Skills Profile (LSP, <a href="./references#CD009533-bbs2-0182" title="PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , LázaroL , BernardoM , Castro-Fornieles J. Assessment of real-world daily-living skills in early-onset schizophrenia trough the Life Skills Profile scale. Schizophr Res2013;145(1-3):95-100.">Puig 2013</a>) </p> </li> </ul> </p> <p>The LSP assesses the real‐world life‐skills of adolescents with early onset schizophrenia. It includes 39 items each of which are scored 1 to 4. The range of the total score on the LSP can be between 39 to 156. The five subscales generated by the instrument are self‐care, interpersonal behaviour, communication‐social contact, nonpersonal social behaviour and autonomy. All items rely on basic, specific and observable behaviours. Lower scores indicate more dysfunction and poorer daily living skills. The LSP is usually scored according to the subjects' functioning over the preceding three months.The LPS was used <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>. </p> <p> <ul id="CD009533-list-0034"> <li> <p>Self Consistency and Congruence Scale (SCSS) (<a href="./references#CD009533-bbs2-0186" title="RogersCR . A theory of therapy, personality, and interpersonal relationship as developed in the client-centered framework. In: KoshS , editors(s). Psychology: A Study of Science. New York: McGraw-hill, 1959:184-256.">Rogers 1959</a>) </p> </li> </ul> </p> <p>The SCSS is based on a scale (<a href="./references#CD009533-bbs2-0186" title="RogersCR . A theory of therapy, personality, and interpersonal relationship as developed in the client-centered framework. In: KoshS , editors(s). Psychology: A Study of Science. New York: McGraw-hill, 1959:184-256.">Rogers 1959</a>) for measuring consistency between self and experience in psychotherapy. The scale consists of 35 items divided into three subscales ‐ self and experience disharmony, self flexibility and self inflexibility answered on a 5‐point Likert scale ranging from totally disagree to totally agree. This scale was used in the study by <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>. </p> </section> <section id="CD009533-sec-0107"> <h6 class="title">6.5. Quality of life scales</h6> <p> <ul id="CD009533-list-0035"> <li> <p>Pediatric Quality of Life Scale (PedsQL) (<a href="./references#CD009533-bbs2-0205" title="Varni, JW, Seid, M, Rode, CA. The PedsQLÔ: Measurement model for the Pediatric Quality of Life Inventory™. Medical Care1999;37:126-139.">Varni 1999</a>) </p> </li> </ul> </p> <p>The PedsQL rates the quality of life of children aged eight to 12 years based on responses related to the preceding month. The scale has a child‐ and a parent‐rated version. <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a> used the PedsQL. </p> </section> </section> <section id="CD009533-sec-0108"> <h5 class="title">7. Missing outcomes</h5> <p>We found that many of the outcomes that we prespecified were not reported by the authors of these trials. None of the authors defined clinically important changes with regard to global state, mental state or global functioning. Mean endpoint scores for these outcomes were reported by several of the trials. For studies reporting a change in cognitive symptoms, there are no standardised and well‐accepted definitions of response or improvement, hence continuous scores were reported for various cognitive outcomes. However, clinically important changes in positive and negative symptoms as captured by common outcome measures like the PANNS and BPRS are well accepted but these were still not reported as categorical data. There were no data on the adverse effects of psychological therapies. Psychological therapies can cause adverse effects inadvertently. Certain psychological interventions in theory may change treatment adherence to medications and result in medication‐related adverse events. No data were available for medication‐related or nonmedication‐related adverse events during the studies. As will be described in the following section, the number of participants who left early from any particular study was reported by most of the studies. However, very few reported the number of hospitalisation episodes or days spent in the hospital. No economic data were reported. </p> </section> <section id="CD009533-sec-0109"> <h5 class="title">8. Studies awaiting assessment</h5> <p>There are three studies awaiting assessment (<a href="./references#CD009533-bbs1-0003" title="">Studies awaiting classification</a>). We have written to the authors and we hope once we hear from the corresponding authors or the study is published, we will consider them for the next version of the review. </p> </section> <section id="CD009533-sec-0110"> <h5 class="title">9. Ongoing studies</h5> <p>There are 13 ongoing studies which we could identify and they are described in the section <a href="./references#CD009533-bbs1-0004" title="">Ongoing studies</a>. Although study protocols were published a few years ago, reviewers couldn't find the full paper. Where possible, we made enquiries to the contact person for the study but were unable to get a response. </p> </section> </section> <section id="CD009533-sec-0111"> <h4 class="title">Excluded studies</h4> <p>We excluded 79 studies for various reasons that are mentioned in <a href="./references#CD009533-sec-0211" title="">Characteristics of excluded studies</a>. One of the studies was not randomised (<a href="./references#CD009533-bbs2-0018" title="BrowningS , CorrigallR , GaretyP , EmsleyR , JolleyS . Psychological interventions for adolescent psychosis: a pilot controlled trial in routine care. European Psychiatry2013;28(7):423-6. ">Browning 2013</a>). Many of the studies did not meet our age criteria and included only few patients in the adolescent age group, while the majority of the participants were adults. Some of the studies compared various service models and were outside the scope of the current review on psychological interventions. The authors of one of the excluded studies (<a href="./references#CD009533-bbs2-0055" title="McFarlaneWR , LevinB , TravisL , LucasFL , LynchS , VerdiM , et al. Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. Schizophrenia Bulletin2015;41(1):30-43. ">McFarlane 2015</a>) corresponded with us describing the difficulties in conducting a randomised trial in adolescents with psychosis. </p> </section> </section> <section id="CD009533-sec-0112"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias was analysed for all included studies. Potential sources of bias are described in the following paragraphs and <a href="#CD009533-fig-0002">Figure 2</a> and <a href="#CD009533-fig-0003">Figure 3</a>. None of the studies were industry‐sponsored. </p> <div class="figure" id="CD009533-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009533-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD009533-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009533-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD009533-sec-0113"> <h4 class="title">Allocation</h4> <p>All of the included studies were randomised trials. However, some of the studies did not report adequate details of randomisation. <a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a> used computer‐generated randomisation sequence. <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a> followed a computer‐generated block randomisation method. <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> followed permuted blocks of with fixed size of eight participants allocated in a 4:4 ratio using a computer‐generated randomisation sequence. <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a> used random number tables for randomisation. <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> used sealed envelopes for randomisation and, as a result, was at high risk of bias. Details of the randomisation process was not described by <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> and, as a result, have high risk of bias. <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> used sealed envelopes for randomisation which is prone to high risk of bias. For the study by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, only the outcome assessors were blinded and, as a result, there was an inadvertent risk of assessors getting to know about the allocation leading high risk of allocation bias. For all the other studies, the methodology of allocation concealment was not described by the authors and, as a result, these other studies have been classified as at 'unclear risk' for allocation bias. </p> </section> <section id="CD009533-sec-0114"> <h4 class="title">Blinding</h4> <p>In four of the included studies (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>, <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>, <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>), the authors clearly stated that the outcome assessments were done by raters who were blind to allocation status and, as a result, they were at low risk of detection bias. In the other three studies (<a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>, <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a> and <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>) the authors have not explicitly stated the process of outcome assessment and, as a result, these studies had unclear risk of detection bias. Two studies (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>, <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>) used the same therapist for both the intervention and control arm; in two studies (<a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>), a majority of the participants were recruited in the same inpatient services and, for one study (<a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>), the participants themselves were aware of the diagnosis and thus all these five studies were at a high risk of performance bias. The performance bias was unclear for two of the other studies (<a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a> and <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>). </p> </section> <section id="CD009533-sec-0115"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition and loss to follow‐up were reported by six of the included studies (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>; <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>; <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>; <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>; <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>; <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>) and were not mentioned by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>. Of the above studies which reported attrition of study participants, reasons for attrition were not clearly stated by <a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>. Intention‐to‐treat analyses were done and reported by <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>, <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> and these studies were at low risk of attrition bias. Other authors (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>, <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>, <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a> and <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>) did not report on intention‐to‐treat analyses and, as a result, were at high risk of attrition bias. </p> </section> <section id="CD009533-sec-0116"> <h4 class="title">Selective reporting</h4> <p>Multiple outcomes were reported by <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> but not all participants completed all the measures. Similarly, <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> did not report clearly results for several outcomes, although interaction analysis was reported for selected outcomes. Thus, <a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a> and <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> were at high risk of reporting bias. The other studies (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>, <a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>, <a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>, <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> and <a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>) reported all outcomes adequately and were at low risk of reporting bias. </p> </section> <section id="CD009533-sec-0117"> <h4 class="title">Other potential sources of bias</h4> <p>None.</p> </section> </section> <section id="CD009533-sec-0118"> <h3 class="title" id="CD009533-sec-0118">Effects of interventions</h3> <p>See: <a href="./full#CD009533-tbl-0001"><b>Summary of findings 1</b> COGNITIVE REMEDIATION THERAPY (CRG) + TREATMENT‐AS‐USUAL (TAU) compared to TAU (all short‐term) for psychosis in adolescents</a>; <a href="./full#CD009533-tbl-0002"><b>Summary of findings 2</b> GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU compared to TAU (all short‐term) for psychosis in adolescents</a>; <a href="./full#CD009533-tbl-0003"><b>Summary of findings 3</b> STRUCTURAL GROUP THERAPY (SGT) + TAU compared to HANDICRAFT GROUP (HC) + TAU (all short‐term) for psychosis in adolescents</a>; <a href="./full#CD009533-tbl-0004"><b>Summary of findings 4</b> COGNITIVE REMEDIATION PROGRAMME (CRP) + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) compared to PTP (all medium‐term) for psychosis in adolescents</a>; <a href="./full#CD009533-tbl-0005"><b>Summary of findings 5</b> COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) compared to COMPUTER GAMES (CG, all short‐term) for psychosis in adolescents</a>; <a href="./full#CD009533-tbl-0006"><b>Summary of findings 6</b> PSYCHOEDUCATIONAL (PE) + MULTIFAMILY TREATMENT (MFT) compared to NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term) for psychosis in adolescents</a> </p> <p>For the six comparators, we have also presented separate 'Summary of findings' tables: <a href="./full#CD009533-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD009533-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD009533-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD009533-tbl-0004">summary of findings Table 4</a>; <a href="./full#CD009533-tbl-0005">summary of findings Table 5</a>; <a href="./full#CD009533-tbl-0006">summary of findings Table 6</a>. For many of the binary outcomes that we had proposed to present in a SOF ('summary of findings' table), no data were available and hence indirect data from continuous scores were used, with appropriate downgrading of the level of evidence. </p> <p>We have presented the two comparisons that assessed the absolute effects of psychological interventions (PI, i.e. comparing PI to treatment‐as‐usual or placebo) first, followed by comparisons where relative effects of psychological interventions were assessed (i.e. comparing PI with a sham therapy or another type of PI). </p> <section id="CD009533-sec-0119"> <h4 class="title">1. COMPARISON 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term) </h4> <p>Two studies (<a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>) compared CRT with TAU (N = 90). </p> <section id="CD009533-sec-0120"> <h5 class="title">1.1 Global state: Average endpoint score (CGAS, high = good)</h5> <p>No global state measures were reported by <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> , although the authors of this study reported in the text of the paper that the intervention did not show any effect on the global state of the participant. <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, however, did report on a 20‐week score on CGAS. Our analysis shows no clear difference between treatment groups for this outcome (MD ‐4.90, 95% CI ‐11.05 to 1.25; participants = 50; studies = 1; very low‐certainty, <a href="./references#CD009533-fig-0004" title="">Analysis 1.1</a>) </p> </section> <section id="CD009533-sec-0121"> <h5 class="title">1.2 Mental state: Overall ‐ Average endpoint score (PANSS total, high = poor)</h5> <p>The authors of one of the studies (<a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>) reported mean endpoint total PANNS score. The total PANNS score at the end of 20 weeks showed that participants receiving TAU had clearly lower scores than those receiving CRT (MD 8.30, 95% CI 0.46 to 16.14; participants = 50; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0005" title="">Analysis 1.2</a>). The authors explained this apparently contradictory finding in the paper by pointing out that in spite of randomisation, the CRT group had a higher mean negative symptom score and total score on PANSS at baseline which could have contributed to this outcome. </p> </section> <section id="CD009533-sec-0122"> <h5 class="title">1.3 Cognitive functioning: Clinically important change ‐ not attaining normal cognitive function </h5> <p>For one study (<a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>), the primary outcomes reported were clinically important change in cognitive functions (memory, cognitive flexibility and planning as measured by: Digit span, Wisconsin Card Sorting Test (WCST) and Modified Six Elements Test (<a href="./references#CD009533-fig-0006" title="">Analysis 1.3</a>)). The study reported number of participants not attaining normal cognitive functioning for these domains. </p> <section id="CD009533-sec-0123"> <h6 class="title">1.3.1 Memory (Digit Span)</h6> <p>There was a clear difference, favouring the CRT group (RR 0.58, 95% CI 0.37 to 0.89; participants = 31; studies = 1; low‐certainty) as compared to TAU group at 3 months post‐treatment follow‐up. </p> </section> <section id="CD009533-sec-0124"> <h6 class="title">1.3.2 Cognitive flexibility (WCST)</h6> <p>Our analysis found no clear difference between treatment groups for this outcome (RR 0.82, 95% CI 0.40 to 1.70; participants = 31; studies = 1). </p> </section> <section id="CD009533-sec-0125"> <h6 class="title">1.3.3 Planning (Modified Six Elements Test)</h6> <p>Our analysis found no clear difference between treatment groups for this outcome (RR 0.94, 95% CI 0.34 to 2.60; participants = 31; studies = 1). </p> </section> </section> <section id="CD009533-sec-0126"> <h5 class="title">1.4 Cognitive functioning: Average endpoint score (various scales, high = poor)</h5> <p>One study (<a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>), reported on cognitive function outcomes using various scales. Our analysis found no clear difference between CRT and TAU group scores for any of the reported cognitive tests (<a href="./references#CD009533-fig-0007" title="">Analysis 1.4</a>). </p> <p> <ul id="CD009533-list-0036"> <li> <p>Verbal Memory (WMS III and RAVLT): MD 1.00, 95% CI ‐4.47 to 6.47; participants = 50; studies = 1 </p> </li> <li> <p>Visual Memory (WMS III): MD 0.70, 95% CI ‐4.60 to 6.00; participants = 50; studies = 1 </p> </li> <li> <p>Working Memory (WISC IV &amp; WAIS III): MD 1.30, 95% CI ‐3.66 to 6.26; participants = 50; studies = 1 </p> </li> <li> <p>Executive Functions (WCST, COWAT &amp; TMT): MD 1.50, 95% CI ‐3.58 to 6.58; participants = 50; studies = 1 </p> </li> <li> <p>Processing Speed: MD ‐2.00, 95% CI ‐10.92 to 6.92; participants = 50; studies = 1</p> </li> <li> <p>Cognitive Composite Score: MD 0.50, 95% CI ‐3.70 to 4.70; participants = 50; studies = 1 </p> </li> </ul> </p> </section> <section id="CD009533-sec-0127"> <h5 class="title">1.5 Global functioning: 1a. Average endpoint score (Life Skills Profile, high = good)</h5> <p>One study measured global functioning using the Life Skills Profile. Our analysis found no clear difference between treatment groups for this outcome (MD ‐2.00, 95% CI ‐11.29 to 7.29; participants = 50; studies = 1; <a href="./references#CD009533-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD009533-sec-0128"> <h5 class="title">1.6 Global functioning: 1b. Average endpoint score (VABS, high = good)</h5> <p>One study measured global functioning using VABS. Our analysis found no clear difference between treatment groups for this outcome (MD 5.90, 95% CI ‐3.03 to 14.83; participants = 50; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD009533-sec-0129"> <h5 class="title">1.7 Leaving the study early ‐ for any reason</h5> <p><a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> reported that four young people left the CRT arm and five young people left the TAU at various stages of the treatment following recruitment into the study. </p> <p><a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> reported that 10 young people left the 'cognitive remediation arm' and 10 people left the 'treatment‐as‐usual arm' and discontinued treatment. One person from the TAU arm was excluded from the final analysis as the diagnosis was changed to bipolar disorder. The post‐treatment assessment could be carried out with 15 young people in the CRT and 14 young people in the TAU. The final analyses included 50 of the 51 participants who were originally randomised. </p> <p>When data from the two studies were combined, our analysis found there was no clear difference between the two treatment groups for number of participants who left the studies early (RR 0.93 95% CI 0.32 to 2.71; participants = 91; studies = 2; low‐certainty; <a href="./references#CD009533-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD009533-sec-0130"> <h5 class="title">1.8 Missing outcomes</h5> <p>Adverse events/effects, service use, social functioning, economics and quality life data were not reported for this comparison. </p> </section> </section> <section id="CD009533-sec-0131"> <h4 class="title">2. COMPARISON 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medication, all short‐term) </h4> <p>One study (<a href="./references#CD009533-bbs2-0003" title="KorenEV , StepuninaNE . Effects of group psychosocial therapy on the functioning of adolescents with schizophrenia spectrum disorders (pilot study). Neuroscience and Behavioral Physiology2015;45(1):26-31. [CSZG: 29803]">Koren 2015</a>), compared GPT with TAU. </p> <section id="CD009533-sec-0132"> <h5 class="title">2.1 Global state: average endpoint score (CGAS, high = good)</h5> <p>Our analysis of reported data for this outcome found a clear difference, favouring GPT over TAU (MD 5.10, 95% CI 1.35 to 8.85; participants = 56; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0011" title="">Analysis 2.1</a>). </p> </section> <section id="CD009533-sec-0133"> <h5 class="title">2.2 Mental state: Overall ‐ average endpoint score (PANSS total, high = poor)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD ‐4.10, 95% CI ‐8.28 to 0.08; participants = 56; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0012" title="">Analysis 2.2</a>). </p> </section> <section id="CD009533-sec-0134"> <h5 class="title">2.3 Quality of life: average endpoint score (PedsQL, high = good)</h5> <p>Our analysis of reported data for this outcome showed a clear difference, favouring GPT over TAU (MD 8.80, 95% CI 0.83 to 16.77; participants = 56; studies = 1; <a href="./references#CD009533-fig-0013" title="">Analysis 2.3</a>). </p> </section> <section id="CD009533-sec-0135"> <h5 class="title">2.4 Leaving the study early ‐ for any reason</h5> <p>Our analysis of reported data found no clear difference in the number of participants leaving the study early from the GPT and TAU groups (RR 0.43, 95% CI 0.15 to 1.28; participants = 56; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0014" title="">Analysis 2.4</a>) </p> </section> <section id="CD009533-sec-0136"> <h5 class="title">2.5 Missing outcomes</h5> <p>Adverse events/effects, service use, cognitive functioning, global functioning, social functioning and economic data were not reported for this comparison. </p> </section> </section> <section id="CD009533-sec-0137"> <h4 class="title">3. COMPARISON 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term) </h4> <p>One study (<a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a>), with a total of 48 participants compared SGT with HG. </p> <section id="CD009533-sec-0138"> <h5 class="title">3.1 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor)</h5> <p>For this outcome, our analysis of reported data showed participants in the SGT group had clearly lower PANSS total scores at short‐term follow‐up (MD ‐2.57, 95% CI ‐4.47 to ‐0.67; participants = 48; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0015" title="">Analysis 3.1</a>). </p> </section> <section id="CD009533-sec-0139"> <h5 class="title">3.2 Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) </h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD ‐0.67, 95% CI ‐1.66 to 0.32; participants = 48; studies = 1; <a href="./references#CD009533-fig-0016" title="">Analysis 3.2</a>). </p> </section> <section id="CD009533-sec-0140"> <h5 class="title">3.3 Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor) </h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 0.12, 95% CI ‐0.87 to 1.11; participants = 48; studies = 1; <a href="./references#CD009533-fig-0017" title="">Analysis 3.3</a>). </p> </section> <section id="CD009533-sec-0141"> <h5 class="title">3.4 Global functioning: average endpoint score (SCCS, high = good) ‐ skewed data</h5> <p>Data reported for this outcome were skewed and we have presented these data as 'other data'. These reported data for global functioning measuring average endpoint score on Self Consistency and Congruence Scale. (<a href="./references#CD009533-fig-0018" title="">Analysis 3.4</a>) </p> </section> <section id="CD009533-sec-0142"> <h5 class="title">3.5 Leaving the study early ‐ for any reason</h5> <p>Noone had left the study early from either treatment group at six weeks. At 12 weeks, the number of participants who had left the GPT group was 5 out of 30 and from the HC group the number was 7 out of 30; our analysis found no clear difference for this outcome (RR 0.71, 95% CI 0.25 to 2.00; participants = 60; studies = 1; low‐certainty; <a href="./references#CD009533-fig-0019" title="">Analysis 3.5</a>). </p> </section> <section id="CD009533-sec-0143"> <h5 class="title">3.6 Missing outcomes</h5> <p>Global state, adverse effects/events, cognitive functioning, service use, social functioning, economic and quality life data were not reported for this comparison. </p> </section> </section> <section id="CD009533-sec-0144"> <h4 class="title">4. COMPARISON 4: COGNITIVE REMEDIATION PROGRAMME (CRP) + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) vs PTP (all medium‐term) </h4> <p>One study (<a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>), with a total of 25 participants, compared a combination of PIs (CRP + PTP) with PTP alone. </p> <section id="CD009533-sec-0145"> <h5 class="title">4.1 Global state ‐ average endpoint score (GAS, high = good)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 1.60, 95% CI ‐6.48 to 9.68; participants = 25; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0020" title="">Analysis 4.1</a>). </p> </section> <section id="CD009533-sec-0146"> <h5 class="title">4.2 Mental state: 1a. Overall ‐ average endpoint score (BPRS total, high = poor)</h5> <p>Total BPRS score showed a trend towards favouring CRP + PTP at the end of one year but our analysis of these average endpoint scores found no clear difference between treatment groups (MD ‐5.40 95% CI ‐16.42 to 5.62; participants = 24; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0021" title="">Analysis 4.2</a>). </p> </section> <section id="CD009533-sec-0147"> <h5 class="title">4.3 Mental state: 1b. Overall ‐ average endpoint score (CBCL, high = poor)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD ‐2.40, 95% CI ‐22.98 to 18.18; participants = 19; studies = 1; <a href="./references#CD009533-fig-0022" title="">Analysis 4.3</a>). </p> </section> <section id="CD009533-sec-0148"> <h5 class="title">4.4 Mental state: 2a. Specific: Positive symptoms ‐ average endpoint score (BPRS positive, high = poor) </h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD ‐2.30, 95% CI ‐7.95 to 3.35; participants = 24; studies = 1; <a href="./references#CD009533-fig-0023" title="">Analysis 4.4</a>). </p> </section> <section id="CD009533-sec-0149"> <h5 class="title">4.5 Mental state: 2b. Specific: Negative symptoms ‐ average endpoint score (BPRS negative, high = poor ) ‐ (skewed data) </h5> <p>Data reported for this outcome were skewed and we have presented these data as 'other data'. These reported data on negative symptoms of mental state measuring average endpoint score on BPRS. (<a href="./references#CD009533-fig-0024" title="">Analysis 4.5</a>). </p> </section> <section id="CD009533-sec-0150"> <h5 class="title">4.6 Cognitive functioning: average endpoint score (various tests, high = good)</h5> <p>On various tests of cognitive functioning, average endpoint scores were reported. Our analyses of reported data showed no clear differences between CRP + PTP group scores and PTP group scores for any of these tests at the one‐year follow‐up. <a href="./references#CD009533-fig-0025" title="">Analysis 4.6</a>. </p> <p> <ul id="CD009533-list-0037"> <li> <p>Attention: BMT: MD ‐1.30, 95% CI ‐6.58 to 3.98; participants = 25; studies = 1</p> </li> <li> <p>Attention: SPAN‐12: MD 2.40, 95% CI ‐2.67 to 7.47; participants = 25; studies = 1; very low‐certainty </p> </li> <li> <p>Attention: Continuous Performance test (CPT): MD ‐8.70, 95% CI ‐21.97 to 4.57; participants = 25; studies = 1 </p> </li> <li> <p>Memory: Kimura Recurring Figures Test: MD 1.00, 95% CI ‐4.48 to 6.48; participants = 24; studies = 1 </p> </li> <li> <p>Memory: Verbal Learning Paradigm: MD ‐2.80, 95% CI ‐10.98 to 5.38; participants = 24; studies = 1 </p> </li> <li> <p>Executive function: WCST perseveration response: MD, 1.20 95% CI ‐4.85 to 7.25; participants = 25; studies = 1 </p> </li> <li> <p>Executive function: Trail making test ‐ B: MD 4.50, 95% CI ‐9.07 to 18.07; participants = 24; studies = 1 </p> </li> </ul> </p> </section> <section id="CD009533-sec-0151"> <h5 class="title">4.7 Missing outcomes</h5> <p>Adverse events/effects, global functioning, social functioning, service use, attrition, economic and quality of life data were not reported for this comparison. </p> </section> </section> <section id="CD009533-sec-0152"> <h4 class="title">5. COMPARISON 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) versus COMPUTER GAMES (CG, all short‐term) </h4> <p>One study (<a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>) with a total of 32 participants compared CACR with nontherapeutic CG. </p> <section id="CD009533-sec-0153"> <h5 class="title">5.1 Global state ‐ average endpoint score (HoNOSCA, high = good)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 2.00, 95% CI ‐1.85 to 5.85; participants = 32; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0026" title="">Analysis 5.1</a>). </p> </section> <section id="CD009533-sec-0154"> <h5 class="title">5.2 Mental state: 1a. Overall ‐ average endpoint score (PANNS total, high = poor)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 3.70, 95% CI ‐10.68 to 18.08; participants = 32; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0027" title="">Analysis 5.2</a>). </p> </section> <section id="CD009533-sec-0155"> <h5 class="title">5.3 Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANNS positive, high = poor) </h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 1.30, 95% CI ‐2.15 to 4.75; participants = 32; studies = 1; <a href="./references#CD009533-fig-0028" title="">Analysis 5.3</a>). </p> </section> <section id="CD009533-sec-0156"> <h5 class="title">5.4 Mental state: 1c. Negative ‐ average endpoint score (PANNS negative, high = poor)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 1.20, 95% CI ‐4.60 to 7.00; participants = 32; studies = 1; <a href="./references#CD009533-fig-0029" title="">Analysis 5.4</a>). </p> </section> <section id="CD009533-sec-0157"> <h5 class="title">5.5 Cognitive functioning: average endpoint score (RBANS, high = good)</h5> <p>For cognitive functioning, average endpoint scores for various domains on the RBANS (total, attention, immediate memory, delayed memory, visuospatial construction and language) were reported. Our analyses of these reported scores found no clear differences between treatment groups for any of these domains (<a href="./references#CD009533-fig-0030" title="">Analysis 5.5</a>). </p> <p> <ul id="CD009533-list-0038"> <li> <p>RBANS total: MD ‐8.70, 95% CI ‐17.40 to 0.00; participants = 32; studies = 1; very low‐certainty </p> </li> <li> <p>RBANS ‐ A (Attention): MD ‐7.90, 95% CI ‐19.07 to 3.27; participants = 32; studies = 1 </p> </li> <li> <p>RBANS ‐ IM (Immediate Memory): MD ‐7.90, 95% CI ‐19.07 to 3.27; participants = 32; studies = 1 </p> </li> <li> <p>RBANS ‐ DM (Delayed Memory): MD ‐4.20, 95% CI ‐16.58 to 8.18; participants = 32; studies = 1 </p> </li> <li> <p>RBANS ‐ VC (Visuospatial Construction): MD 0.10, 95% CI ‐9.20 to 9.40; participants = 32; studies = 1 </p> </li> <li> <p>RBANS ‐ L (Language): MD ‐13.40, 95% CI ‐25.42 to ‐1.38; participants = 32; studies = 1 </p> </li> </ul> </p> </section> <section id="CD009533-sec-0158"> <h5 class="title">5.6 Global functioning: Overall ‐ average endpoint score (SOFAS, high = good)</h5> <p>Analyses of average endpoint SOFAS scores showed no clear difference between treatment groups (MD ‐0.70, 95% CI ‐7.76 to 6.36; participants = 32; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0031" title="">Analysis 5.6</a>). </p> </section> <section id="CD009533-sec-0159"> <h5 class="title">5.7 Leaving the study early ‐ for any reason</h5> <p>Three participants from the CACR group and one from CG group did not participate in the study until completion and left early due to lack of interest in the programme or being transferred to another treatment centre. Our analysis of these data found no clear difference in numbers leaving early from each group (RR 2.33, 95% CI 0.27 to 20.09; participants = 32; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0032" title="">Analysis 5.7</a>). </p> </section> <section id="CD009533-sec-0160"> <h5 class="title">5.8 Missing outcomes</h5> <p>Adverse effects/events, social functioning, service use, economics and quality life data were not reported for this comparison. </p> </section> </section> <section id="CD009533-sec-0161"> <h4 class="title">6. COMPARISON 6: PSYCHOEDUCATIONAL (PE) <i>+</i> MULTIFAMILY TREATMENT (MFT) vs NONSTRUCTURED INTERVENTION (NSGT, all long‐term) </h4> <p>One study (<a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a>) with a total of 49 participants compared a combination of psychological interventions (PE + MFT) with a nonstructured intervention (NSGT). </p> <section id="CD009533-sec-0162"> <h5 class="title">6.1 Global state ‐ average endpoint score (CGAS, high = good, long term)</h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD 3.38, 95% CI ‐4.87 to 11.63; participants = 49; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0033" title="">Analysis 6.1</a>). </p> </section> <section id="CD009533-sec-0163"> <h5 class="title">6.2 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor)</h5> <p>Our analysis of reported average endpoint PANSS total scores showed no difference between PE + MFT group and NGST group at two‐year follow‐up (MD ‐8.23, 95% CI ‐17.51 to 1.05; participants = 49; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0034" title="">Analysis 6.2</a>). </p> </section> <section id="CD009533-sec-0164"> <h5 class="title">6.3 Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) </h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD ‐0.85, 95% CI ‐6.65 to 4.95; participants = 49; studies = 1; <a href="./references#CD009533-fig-0035" title="">Analysis 6.3</a>). </p> </section> <section id="CD009533-sec-0165"> <h5 class="title">6.4 Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor) </h5> <p>Our analysis of reported data for this outcome found no clear difference between the treatment groups (MD ‐2.08, 95% CI ‐5.31 to 1.15; participants = 49; studies = 1; <a href="./references#CD009533-fig-0036" title="">Analysis 6.4</a>). </p> </section> <section id="CD009533-sec-0166"> <h5 class="title">6.5 Service use: 1. Hospital admission: number of participants needing admission</h5> <p><a href="./references#CD009533-bbs2-0001" title="ArangoC , CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , et al. Psychoeducational group intervention for adolescents with psychosis and their families. A two-year follow-up: the PIENSA trial. Neuropsychopharmacology2015;40:S469-70. [CSZG: 33278]ArangoC . Psychosocial interventions in first episode psychosis. Schizophrenia Bulletin2015;41:S300. [CSZG: 29380]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(6):688-96. [CSZG: 29028]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial: corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):1066. [CSZG: 33291]CalvoA , MorenoM , Ruiz-SanchoA , Rapado-CastroM , MorenoC , Sanchez-GutierrezT , et al. Psychoeducational group intervention for adolescents with psychosis and their families: a two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(12):984-90. [CSZG: 33215]Rapado-CastroM , CalvoA , MorenoC , Sanchez-GutierrezT , ChiclanaG , Ruiz-SanchoA , et al. Family psycho-education in early onset psychosis: effects on relapse and on the use of clinical services after the first psychotic episode (results derived from the PIENSA program). Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60:S284. [CSZG: 29938]">Calvo 2014</a> reported numbers of participants needing hospital admission. Our analysis of reported two‐year data found no clear difference in the numbers admitted from each group (RR 0.84, 95% CI 0.36 to 1.96; participants = 49; studies = 1; low‐certainty; <a href="./references#CD009533-fig-0037" title="">Analysis 6.5</a>). </p> </section> <section id="CD009533-sec-0167"> <h5 class="title">6.6 Service use: 2. Number of days in hospital (high = poor)</h5> <p>Our analysis of reported data found no clear difference in the number of days participants from each group spent in hospital (MD ‐1.81, 95% CI ‐10.13 to 6.51; participants = 49; studies = 1; very low‐certainty; <a href="./references#CD009533-fig-0038" title="">Analysis 6.6</a>). </p> </section> <section id="CD009533-sec-0168"> <h5 class="title">6.7 Leaving the study early ‐ for any reason</h5> <p>Our analysis of reported attrition data found no clear difference in number of participants leaving the study early from each group (RR 0.52, 95% CI 0.10 to 2.60; participants = 55; studies = 1; low‐certainty; <a href="./references#CD009533-fig-0039" title="">Analysis 6.7</a>). </p> </section> <section id="CD009533-sec-0169"> <h5 class="title">6.8 Missing outcomes</h5> <p>Adverse effects/events, cognitive functioning, global functioning, social functioning, economics and quality life data were not reported for this comparison. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009533-sec-0170" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009533-sec-0170"></div> <section id="CD009533-sec-0171"> <h3 class="title" id="CD009533-sec-0171">Summary of main results</h3> <section id="CD009533-sec-0172"> <h4 class="title">1. Cognitive Remediation Therapy (CRT) + Treatment‐As‐Usual (TAU) versus TAU (all short‐term) </h4> <p>Two studies (<a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>; <a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a> ) contributed data for a comparison of Cognitive Remediation Therapy (CRT) with Treatment‐as‐Usual (TAU). Both the studies were comparable and had similar inclusion criteria but used variable measures for outcomes so we could only combine attrition data for meta‐analyses (<a href="./references#CD009533-fig-0010" title="">Analysis 1.7</a>; low‐certainty). </p> <p>Analysis of 20‐week data reported by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a>, showed no clear difference in global state scores (<a href="./references#CD009533-fig-0004" title="">Analysis 1.1</a>; very low‐certainty) and a clear difference in mental state continuous scores favouring TAU (<a href="./references#CD009533-fig-0005" title="">Analysis 1.2</a>; very low‐certainty), this evidence suggesting adding CRT to TAU appears to have little or no effect on a participant's global state and TAU alone may be better for mental state. This apparently conflicting finding on the mental state outcome could be due to the baseline PANSS score being significantly lower in the control arm as compared to the intervention arm. The study thus does not provide any evidence favouring the use of cognitive remediation therapy in adolescents with psychosis as regards the outcome of mental state. (<a href="./references#CD009533-bbs2-0007" title="ISRCTN75187865. Cognitive remediation for young people with schizophrenia. www.isrctn.com/ (accessed 5 May 2006). NewtonE , LandauS . Cognitive remediation therapy (CRT): a new psychological treatment for young patients with schizophrenia. Schizophrenia Research2006;86(Suppl 1):S143-4. [CSZG: 13391]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research2007;94(1-3):221-30. [CSZG: 14863]WykesT , NewtonE , LandauS , RiceC , ThompsonN , FrangouS . Remediation in adolescent onset results of a randomised control trial. Schizophrenia Bulletin2007;33(2):610. [CSZG: 15255]WykesT , ReederC , WilliamsC , CornerJ , RiceC , EverittB . Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research2003;61(2-3):163-74. [CSZG: 11223]WykesT . Cognitive remediation therapy (CRT) for young people with schizophrenia. In: 2nd International Conference on Early Psychosis; 2000 Mar 31 - Apr 2, New York, USA. 2000. ">Wykes 2007</a>) showed that in the medium term, clearly more participants in the CRT group showed improvement in short‐term memory as tested by the Digit Span Test at six months (<a href="./references#CD009533-fig-0006" title="">Analysis 1.3</a>; very low‐certainty) but other results from data reported by <a href="./references#CD009533-bbs2-0004" title="NCT01701609. Cognitive remediation therapy (CRT) in adolescents with EOS. ClinicalTrials.gov/show/NCT01701609 (accessed: 5 October 2012). [CSZG: 24763]PuigO , PenadésR , BaezaI , De la SernaE , Sánchez-GistauV , BernardoM , et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53(8):859-68. [CSZG: 28850]PuigO , PenadesR , BaezaI , De La SernaE , Sanchez-GistauV , BernardoM , et al. Treatment of cognitive deficits in adolescents with early-onset schizophrenia: a randomised controlled trial of cognitive remediation. European Neuropsychopharmacology2013;23:S611. [CSZG: 28353]PuigO . Treatment of cognitive impairment in adolescents with early-onset schizophrenia through cognitive remediation therapy. Early Intervention in Psychiatry2018;12(Suppl 1):41. ">Puig 2014</a> showed no clear improvement in verbal memory, visual memory, working memory, processing speed, executive functioning and cognitive composite score in the short term at 20 weeks (<a href="./references#CD009533-fig-0007" title="">Analysis 1.4</a>). Attrition rates were similar (<a href="./references#CD009533-fig-0010" title="">Analysis 1.7</a>; very low‐certainty). However, these results are based on data from small studies where allocation and blinding were problematic, so these estimates of effect must be viewed with considerable caution. It is also likely that cognitive function, mental state and global state were interrelated in some way and standard measures are needed in future studies to be meaningfully compared. </p> </section> <section id="CD009533-sec-0173"> <h4 class="title">2. Group Psychosocial Therapy plus TAU versus TAU (all short‐term)</h4> <p>One study contributed data for a comparison of Group Psychosocial therapy (GPT) plus usual medications with usual medications alone (TAU). There was a clear difference in the mean endpoint CGAS scores, GPT (very low‐certainty; <a href="./references#CD009533-fig-0011" title="">Analysis 2.1</a>), however, the same study did not find any clear difference in mental state scores on the PANSS (very low‐certainty; <a href="./references#CD009533-fig-0012" title="">Analysis 2.2</a> ). There was a clear difference in quality of life scores (not a SOF outcome) measured (very low‐certainty; <a href="./references#CD009533-fig-0013" title="">Analysis 2.3</a>). The authors did not report random sequence generation, allocation concealment or blinding of participants and assessors. There was no clearly reported intention‐to‐treat analysis. These factors make the evidence of very low certainty (<a href="./full#CD009533-tbl-0002">summary of findings Table 2</a>). The reason for not finding clear differences in the psychopathology scores but finding a clear difference in the quality of life score is intriguing and could be because group therapy has more impact on interpersonal domains as opposed to the individual. The above diverse elements used in the group is likely to be engaging for adolescents and could hold the attention of young people who may be interested to learn to communicate with their peers. However, the nature of the intervention makes it difficult to understand the most therapeutic component of the psychological treatment that contributed to the positive results. </p> </section> <section id="CD009533-sec-0174"> <h4 class="title">3. Structural Group Therapy + TAU versus Handicraft Group + TAU (all short‐term)</h4> <p><a href="./references#CD009533-bbs2-0005" title="曾红玲, 谢俊, 孙科, 徐汉明, 马筠. 结构式团体心理治疗对精神分裂症青少年患者自我和谐感的疗效. 中国民康医学2014;26(12):17-9. [CSZG: 31206]SheP , ZengH , YangB . Effect of self-consistency group intervention for adolescents with schizophrenia: an inpatient randomized controlled trial. Journal of Psychiatric Research2016;73:63-70. [CSZG: 33576]">She 2016</a> compared structural group therapy with a handicraft group (both interventions were in addition to normal care). The study found a clear difference in mental state scores on PANSS between these interventions, favouring structured group therapy (very low‐certainty; <a href="./references#CD009533-fig-0015" title="">Analysis 3.1</a>) This study was conducted specifically in older adolescents with schizophrenia. Having a narrow age range of the participants made the study sample quite homogenous. The authors did not report binary outcome data for mental state or details regarding allocation concealment; also, participants were not blinded and no intention‐to‐treat analysis was reported. This made the evidence of very low certainty (<a href="./full#CD009533-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD009533-sec-0175"> <h4 class="title">4. Cognitive Remediation Programme + Psychoeducational Treatment Programme (CRP + PTP) versus PTP (all medium‐term) </h4> <p>One study (<a href="./references#CD009533-bbs2-0006" title="UelandT , RundBR . A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis. Acta Psychiatrica Scandinavica2004;(1):70-4. [CSZG: 10119]UelandT , RundBR . Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatrica Scandinavica2005;111(3):193-201. ">Ueland 2004</a>) compared CRP + PTP with PTP alone. No clear difference in the global state, mental state or cognitive functioning was found between the intervention and comparator arm even when the participants were followed up at the end of one year (very low‐certainty; <a href="./references#CD009533-fig-0020" title="">Analysis 4.1</a>; <a href="./references#CD009533-fig-0021" title="">Analysis 4.2</a>; <a href="./references#CD009533-fig-0025" title="">Analysis 4.6</a>). This lack of superiority of CRP could be because the comparator group, having received psychoeducation that may have indirectly influenced the positive, negative and cognitive symptoms by motivating participants to have a regular routine, plan their activities, improve medication adherence, reduced expressed emotions in family members and addressed their other day‐to‐day needs. The studies used 'sealed envelopes' as a method of randomisation and this has been often criticised for various methodological issues. The studies also did not report an intention‐to‐treat analysis which is routinely advocated as reducing bias. Many participants did not complete several of the questionnaires at many time points and this is not explained in the discussion. Using too many questionnaires with a small sample size poses an additional problem of spurious or chance associations due to the effects of multiple testing. It is advisable to do a sample size calculation a priori, based on the number of questionnaires to be used. Lack of details in the method of allocation concealment, method of blinding of participants and personnel, nonsignificant estimates of effect with wide confidence intervals and other factors make the evidence of very low certainty (<a href="./full#CD009533-tbl-0004">summary of findings Table 4</a>). The findings were of very low certainty as they were based on a single study with a small sample size. </p> </section> <section id="CD009533-sec-0176"> <h4 class="title">5. Computer‐Assisted Cognitive Remediation Programme versus Computer Games (all short‐term)</h4> <p>Computerised therapies have been tested for psychiatric disorders and these may be particularly suitable for adolescents who are often more gadget‐friendly than adults. Similarly, over the years, many of the neuropsychological tests have been developed to be administered through computer (<a href="./references#CD009533-bbs2-0164" title="LezakM . Neuropsychological assessment. New York: Oxford University Press, 1995.">Lezak 1995</a>). Use of a computer in cognitive remediation involving multiple cognitive tasks can be scored in real time to give feedback and reinforce participation in adolescents with psychosis. One study (<a href="./references#CD009533-bbs2-0002" title="HolzerL , UrbenS , PassiniCM , JaugeyL , HerzogMH , HalfonO , et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behavioural and Cognitive Psychotherapy2014;42(4):421-34. [CSZG: 29061]HolzerL , UrbenS , PihetS , JaugeyL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short-term and long-term outcomes. Neuropsychiatrie de L'Enfance et de L'Adolescence2012;60(5 Suppl):S71. [CSZG: 29863]JaugeyL , UrbenS , PihetS , HalfonO , HolzerL . Short-and long-term outcomes of a randomized controlled trial of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis. Biological Psychiatry2012;8(Suppl 1):84S. [CSZG: 24234]TorrisiR , HolzerL , PihetS , SuterS , AeberhardA , PellandaV , et al. Computer-assisted cognitive remediation program for adolescents at high risk of psychosis or with psychotic disorders: preliminary results. In: 15th Biennial Winter Workshop in Psychoses; 2009 Nov 15-18; Barcelona, Spain. 2009. UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . A randomized controlled trial of the effectiveness of a computer-assisted cognitive remediation (CACR) program in adolescents with psychosis or at high risk of psychosis: short term and long term outcomes. Early Intervention in Psychiatry2012;6:41. [CSZG: 24984]UrbenS , PihetS , JaugeyL , HalfonO , HolzerL . Computer-assisted cognitive remediation in adolescents with psychosis or at risk for psychosis: a 6-month follow-up. Acta Neuropsychiatrica2012;24(6):328-35. [CSZG: 35735]">Holzer 2014</a>) compared computer‐assisted cognitive remediation to nontherapeutic computer games for adolescents with psychosis. Based on very low certainty of evidence, no clear difference in global state HoNOSCA scores was found between intervention and control arms following study completion (very low‐certainty; <a href="./references#CD009533-fig-0026" title="">Analysis 5.1</a>). Even on measurements of mental state using the PANSS, there was no clear difference between the two group's average endpoint scores (<a href="./references#CD009533-fig-0027" title="">Analysis 5.2</a>). Unavailability of binary outcomes except for attrition, lack of adequately described allocation concealment, and participants and personnel involved in the trial not being blind to the allocated intervention, all made the evidence of very low to low certainty (<a href="./full#CD009533-tbl-0005">summary of findings Table 5</a>). Failure to show efficacy of computerised CRP by the study should take into account the small sample size, leading to possible type II error. Moreover, the control arm of computer games may inadvertently have helped the adolescents use a diverse range of cognitive processes such as visual scanning, planning, memory and auditory processing, thus diluting any effect of the intervention. It would be interesting to compare CRP with other control treatments in the future. </p> <p>Cognitive functioning was measured using RBANS ‐ Repeatable Battery for the Assessment of Neuropsychological Status (<a href="./references#CD009533-bbs2-0183" title="RandolphC , TierneyMC , MohrE , ChaseTN . The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of clinical and experimental neuropsychology1998;20(3):310-9. [PMID: 9845158]">Randolph 1998</a>). The baseline scores were different between the groups as regards the RBANS‐Language score with the control group scoring higher (Mann Whitney Z score 2.31, P &lt; 0.05). The outcome assessments were done at the end of eight weeks. At the end of eight weeks, the RBANS score showed a difference in the RBANS‐Language subscale for the two groups, but, when this score was controlled for the baseline score using a Wilcoxon test, it lost its significance. The total score on RBANS showed improvement in both groups and did not show any clear difference between the two groups (very low‐certainty; <a href="./references#CD009533-fig-0030" title="">Analysis 5.5</a>). Again, the findings are very uncertain. </p> </section> <section id="CD009533-sec-0177"> <h4 class="title">6. Psychoeducational + Multifamily Treatment (PE + MFT) versus Nonstructured Group Therapy (NSGT, all long‐term) </h4> <p>One study compared psychoeducational and multifamily treatment with nonstructured supportive treatment. The authors published the findings of a follow‐up of nine months and two years, respectively. The global state (very low‐certainty; <a href="./references#CD009533-fig-0033" title="">Analysis 6.1</a>) and mental state (very low‐certainty; <a href="./references#CD009533-fig-0034" title="">Analysis 6.2</a>) at two years did not differ between the groups. This study combined individual therapy and family group therapy and was feasible in an outpatient setting. Binary outcomes were not available for global state or mental state. The same therapists intervened for the intervention and comparator groups and proper intention‐to‐treat analyses were not reported. These factors made the results relating to global state and mental state of very low certainty. Service utilisation data as regards number of hospital admissions at the end of two years (low‐certainty; <a href="./references#CD009533-fig-0037" title="">Analysis 6.5</a>) and leaving the study early at the end of two years (low‐certainty; <a href="./references#CD009533-fig-0039" title="">Analysis 6.7</a>) did not show any difference between the groups. </p> </section> </section> <section id="CD009533-sec-0178"> <h3 class="title" id="CD009533-sec-0178">Overall completeness and applicability of evidence</h3> <p>The review included evidence from seven studies (n = 319). Five of the seven studies reported short‐term outcomes (up to 6 months), one study had reported medium‐term follow‐up of one year duration and one study had reported longer‐term follow‐up of up to two years. A variety of interventions were studied including cognitive remediation therapy programme, computerised cognitive remediation, family therapy, psychoeducation and group therapy. The heterogeneity of the interventions made it difficult for us to combine findings of multiple studies together. All studies included mostly adolescent patients and a majority of the participants of the included studies were 17 years old or less, which makes this review relevant to this age group. All studies, except one, were conducted in developed countries and thus the evidence generated in this review should be used with caution in low‐ and middle‐income countries. Some authors did not publish means and standard deviations of scores following the intervention and these data could not be used in this review. It is interesting that none of the studies reported on the adverse events or harm associated with psychological interventions during the study period. This is a serious flaw in the reporting of studies covered in this review. Earlier literature (<a href="./references#CD009533-bbs2-0165" title="LilienfeldSO . Psychological Treatments That Cause Harm. Perspect Psychol Sci2007;2(1):53-70.">Lilienfeld 2007</a>) have discussed the paucity of literature on the topic of adverse events or harm associated with psychological interventions and methodological problems in quantifying potential harm caused by therapy (<a href="./references#CD009533-bbs2-0120" title="DimidjianS , HollonSD . How would we know if psychotherapy were harmful?Am Psychol2010;65(1):22-33.">Dimidjian 2010</a>). Adolescents with psychosis are a very vulnerable group and we suggest that future clinical trials of psychological therapies for adolescents with psychosis should follow uniform adverse result reporting methods. </p> </section> <section id="CD009533-sec-0179"> <h3 class="title" id="CD009533-sec-0179">Quality of the evidence</h3> <p>Quality and style of reporting for many of the studies could have been improved (<a href="#CD009533-fig-0003">Figure 3</a>). More than half of the studies had either not discussed the details of randomisation or had used suboptimal methods like ‘sealed envelopes’ for randomisation. Most studies were unclear about the allocation concealment. </p> <p>The majority of the studies had small sample size and this increased the chances of bias due to unequal distribution of potential confounders between intervention and control arms. Small sample size has the added problem of multiple testing and positive results due to chance associations. However, some of the studies were well conducted and one of the studies had a long follow‐up of two years duration which is commendable. </p> </section> <section id="CD009533-sec-0180"> <h3 class="title" id="CD009533-sec-0180">Potential biases in the review process</h3> <p>The authors of the review tried to minimise bias in the review process by following standard guidelines of the Cochrane Schizophrenia Group and also the Cochrane Handbook. The search for literature was done centrally at the editorial centre of the Cochrane Schizophrenia Group and a record of the various steps of data acquisition, data extraction and analysis was systematically stored by the review team. We screened a large number of conference abstracts but these did not contribute significantly to the data. </p> </section> <section id="CD009533-sec-0181"> <h3 class="title" id="CD009533-sec-0181">Agreements and disagreements with other studies or reviews</h3> <p>Most reviews on treatment of adolescents with psychosis extrapolated findings from studies done on young adults (<a href="./references#CD009533-bbs2-0198" title="StaffordMR , Mayo-WilsonE , LoucasCE , JamesA , HollisC , BirchwoodM , et al. Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis. PloS one2015;10(2):e0117166. [PMID: 25671707]">Stafford 2015</a>). The National Institute of Clinical Excellence (<a href="./references#CD009533-bbs2-0173" title="NICE: National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management. CG 1552013.">NICE 2013</a>) advocates use of culturally appropriate psychotherapies for children and young people with psychosis. It also mentions that psychological therapy should take into account the young person’s developmental level, emotional maturity, cognitive capacity, sight or hearing problems, and language difficulties. NICE recommends family therapy in adolescents with psychosis. We did not find any evidence in support of the use of family therapy for adolescents with psychosis in our review based on the studies specifically focused on adolescents. However we would like to reiterate that it is important to note lack of evidence for use of formal family therapy does not rule out the usefulness of therapeutic value of a supportive family for this group of young people. In our review, there was some evidence to support the use of group therapy for adolescents with psychosis based on low and very low quality of evidence. We cannot comment on Cognitive Behaviour Therapy (CBT) as a therapeutic modality for adolescents with psychosis as we did not find any randomised trials using CBT for adolescents with psychosis that met the inclusion criteria of the present review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009533-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009533-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009533-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009533-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 1: Global state: 1a. Average endpoint score (CGAS, high = good)" data-id="CD009533-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 1: Global state: 1a. Average endpoint score (CGAS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 2: Mental state: Overall ‐ average endpoint score (PANSS total, high = poor)" data-id="CD009533-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 2: Mental state: Overall ‐ average endpoint score (PANSS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 3: Cognitive functioning: 1. Clinically important change ‐ not attaining normal cognitive function" data-id="CD009533-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 3: Cognitive functioning: 1. Clinically important change ‐ not attaining normal cognitive function </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 4: Cognitive functioning: 2. Average endpoint score (various scales, high = poor)" data-id="CD009533-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 4: Cognitive functioning: 2. Average endpoint score (various scales, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 5: Global functioning: 1a. Average endpoint score (Life Skills Profile, high = good)" data-id="CD009533-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 5: Global functioning: 1a. Average endpoint score (Life Skills Profile, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 6: Global functioning: 1b. Average endpoint score (VABS, high = good)" data-id="CD009533-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 6: Global functioning: 1b. Average endpoint score (VABS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 7: Leaving the study early ‐ for any reason" data-id="CD009533-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term), Outcome 7: Leaving the study early ‐ for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 1: Global state: average endpoint score (CGAS, high = good)" data-id="CD009533-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 1: Global state: average endpoint score (CGAS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 2: Mental state: Overall ‐ average endpoint score (PANSS total, high = poor))" data-id="CD009533-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 2: Mental state: Overall ‐ average endpoint score (PANSS total, high = poor)) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 3: Quality of life: average endpoint score (PedsQL, high = good)" data-id="CD009533-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 3: Quality of life: average endpoint score (PedsQL, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 4: Leaving the study early ‐ for any reason" data-id="CD009533-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term), Outcome 4: Leaving the study early ‐ for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 1: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor)" data-id="CD009533-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 1: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 2: Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor)" data-id="CD009533-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 2: Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 3: Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor)" data-id="CD009533-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 3: Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0018"> <p> <div class="table" id="CD009533-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Global functioning: average endpoint score on Self Consistency and Congruence Scale (SCCS, high = good) ‐ skewed data </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>N</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>SCSS total score</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>She 2016</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Structural group therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Handicraft group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 4: Global functioning: average endpoint score on Self Consistency and Congruence Scale (SCCS, high = good) ‐ skewed data </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0018">Navigate to figure in review</a></div> </div> <div class="figure" id="CD009533-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 5: Leaving the study early ‐ for any reason" data-id="CD009533-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term), Outcome 5: Leaving the study early ‐ for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 1: Global state ‐ average endpoint score (GAS, high = good)" data-id="CD009533-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 1: Global state ‐ average endpoint score (GAS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 2: Mental state: 1a. Overall ‐ average endpoint score (BPRS total, high = poor)" data-id="CD009533-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 2: Mental state: 1a. Overall ‐ average endpoint score (BPRS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 3: Mental state: 1b. Overall ‐ average endpoint score (CBCL, high = poor)" data-id="CD009533-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 3: Mental state: 1b. Overall ‐ average endpoint score (CBCL, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 4: Mental state: 2a. Specific: Positive symptoms ‐ average endpoint score (BPRS positive, high = poor)" data-id="CD009533-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 4: Mental state: 2a. Specific: Positive symptoms ‐ average endpoint score (BPRS positive, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0024"> <p> <div class="table" id="CD009533-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Mental state: 2b. Specific: Negative symptoms ‐ average endpoint score (BPRS negative, high = poor ) ‐ (skewed data) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>N</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Ueland 2004</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRP + PTP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PTP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 5: Mental state: 2b. Specific: Negative symptoms ‐ average endpoint score (BPRS negative, high = poor ) ‐ (skewed data) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0024">Navigate to figure in review</a></div> </div> <div class="figure" id="CD009533-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 6: Cognitive functioning: average endpoint score (various tests, high = good)" data-id="CD009533-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term), Outcome 6: Cognitive functioning: average endpoint score (various tests, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 1: Global state ‐ average endpoint score (HoNOSCA, high = good)" data-id="CD009533-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 1: Global state ‐ average endpoint score (HoNOSCA, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 2: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor)" data-id="CD009533-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 2: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 3: Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor)" data-id="CD009533-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 3: Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 4: Mental state: 1c. Negative ‐ average endpoint score (PANSS negative, high = poor)" data-id="CD009533-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 4: Mental state: 1c. Negative ‐ average endpoint score (PANSS negative, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 5: Cognitive functioning: average endpoint score (RBANS, high = good)" data-id="CD009533-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 5: Cognitive functioning: average endpoint score (RBANS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 6: Global functioning: Overall ‐ average endpoint score (SOFAS, high = good)" data-id="CD009533-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 6: Global functioning: Overall ‐ average endpoint score (SOFAS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 7: Leaving the study early ‐ for any reason" data-id="CD009533-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term), Outcome 7: Leaving the study early ‐ for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 1: Global state ‐ average endpoint score (CGAS, high = good)" data-id="CD009533-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 1: Global state ‐ average endpoint score (CGAS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 2: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor)" data-id="CD009533-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 2: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 3: Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor)" data-id="CD009533-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 3: Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 4: Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor)" data-id="CD009533-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 4: Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 5: Service use: 1. Hospital admission: number of participants needing addmission" data-id="CD009533-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 5: Service use: 1. Hospital admission: number of participants needing addmission </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 6: Service use: 2. Number of days in hospital (high = poor)" data-id="CD009533-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 6: Service use: 2. Number of days in hospital (high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009533-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/urn:x-wiley:14651858:media:CD009533:CD009533-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 7: Leaving the study early ‐ for any reason" data-id="CD009533-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_t/tCD009533-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term), Outcome 7: Leaving the study early ‐ for any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/media/CDSR/CD009533/image_n/nCD009533-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009533-tbl-0007"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Design for a future study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: Randomised and described in detail in the study protocol and report. Appropriate measures to maintain allocation concealment needs to be implemented. </p> <p>Blinding: The trial should be double‐blind.</p> <p>Outcome Assessor: Researchers assessing outcome should be different from those who delivered the psychological interventions and should also be blind to the nature of the intervention. </p> <p>Duration: One year or more</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age: 13 to 18 years</p> <p>Gender: Equal representation of both genders</p> <p>Diagnosis: adolescents with psychosis as per clear operational criteria</p> <p>N = 200</p> <p>Setting: Outpatient setting is preferred. Patients requiring admission to inpatient adolescent units may not be an ideal group to received structured therapy. A combination of inpatient and outpatients will make the study population heterogenous. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Technique of psychotherapy: Cognitive remediation therapy, cognitive behaviour therapy, family therapy or group therapy. </p> <p>Duration of psychological intervention: at least 8 weeks</p> <p>Comparator: Treatment‐as‐usual</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcomes:</p> <p>Global state: Improved to significant degree</p> <p>Mental state: Significant clinical improvement as suggested by change of psychopathology score or relapse </p> <p>Global functioning: Significant change in global functioning as suggested by global functioning score or return to academic education or vocational training </p> <p>Leaving the study early: Intention‐to‐treat analysis should be conducted taking into account all participants in the intervention and comparator arms following randomisation even if they have left the study early. Comparative data for both groups should be presented. </p> <p>Service utilisation: Number of inpatient admissions and crisis presentations for one year following interventions </p> <p>Quality of life: Significant improvement in quality of life score</p> <p>Economic outcomes: Cost of interventions should be quantified.</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Design for a future study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009533-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">COGNITIVE REMEDIATION THERAPY (CRG) + TREATMENT‐AS‐USUAL (TAU) compared to TAU (all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COGNITIVE REMEDIATION THERAPY + TREATMENT‐AS‐USUAL compared to TREATMENT‐AS‐USUAL (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Inpatients and outpatients </p> <p><b>Intervention:</b> COGNITIVE REMEDIATION THERAPY + TREATMENT‐AS USUAL (CRT + TAU)<br/><b>Comparison:</b> TREATMENT‐AS‐USUAL (TAU) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TREATMENT‐AS‐USUAL (TAU)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COGNITIVE REMEDIATION THERAPY + TREATMENT‐AS‐USUAL (CRT + TAU)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Average endpoint score CGAS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the control group was 55.4 + 12.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the intervention group was</p> <p><b>4.9 lower</b><br/>(11.05 lower to 1.25 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state:</b> </p> <p>Average endpoint score PANNS (high score = poor)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score (PANSS) in the control group was 54.2 + 12.0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score (PANSS) in the intervention group was <b>8.30 higher</b> </p> <p>(0.46 higher to 16.14 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1,2,3,4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cognitive functioning: clinically important change</b> </p> <p>Not attaining normal cognitive function (Memory Digit Span)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/>(0.37 to 0.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>31<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>2,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1,000 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>580 per 1,000</b><br/>(370 to 890) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning:</b> </p> <p>Average endpoint VABS Score (high score = good)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint VABS score for the control arm was 73.5 + 19.5</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint VABS score for the intervention arm was <b>5.90 higher</b> (3.03 lower to 14.83 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>Very Low <sup>2,3,4,5,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Clinically important effect</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service use:</b> </p> <p>Hospital admission for any reason</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/>(0.32 to 2.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>91<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>2,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1,000</b><br/>(36 to 301) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (the results were imprecise with the estimated change in mean CGAS score and the mean PANSS score had a wide confidence interval). </p> <p><sup>2</sup> Downgraded by one level (the author reported that the study was a single‐blind study and likely the participants were not blind to the allocation status as the comparator arm was treatment‐as‐usual. This increased the risk of bias of the study findings). </p> <p><sup>3</sup> Downgraded by one level (binary outcome was unavailable. We therefore employed the mean endpoint CGAS score, PANSS score and Composite Cognitive score as alternative indicators). </p> <p><sup>4</sup> Downgraded by one level (majority of participants in one of the studies were recruited while they were inpatients. The comparator group was treatment‐as‐usual and the intervention arm was CRT. Therapists, patients and relatives were likely aware of the allocated arm. This design could pose a high risk of bias due to compromise in allocation concealment). </p> <p><sup>5</sup> Downgraded by one level (data used are from one trial with small sample size). </p> <p><sup>6</sup> Downgraded by one level (in one of the studies, there were fewer than 50% left the study early following randomisation. The study did not report the details of the intention‐to‐treat analysis). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">COGNITIVE REMEDIATION THERAPY (CRG) + TREATMENT‐AS‐USUAL (TAU) compared to TAU (all short‐term) for psychosis in adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009533-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU compared to TAU (all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GROUP PSYCHOSOCIAL THERAPY + TREATMENT‐AS‐USUAL compared to TREATMENT‐AS‐USUAL (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Outpatient<br/><b>Intervention:</b> GROUP PSYCHOSOCIAL THERAPY + USUAL MEDICATION (GPT + TAU)<br/><b>Comparison:</b> USUAL MEDICATION (TAU) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TREATMENT‐AS‐USUAL (TAU)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with GROUP PSYCHOSOCIAL THERAPY + TREATMENT‐AS‐USUAL (GPT + TAU)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Mean endpoint score (CGAS, high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the control group was</p> <p>49.7 + 6.8</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (CGAS) in the intervention group was</p> <p><b>5.1 higher</b><br/>(1.35 higher to 8.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental State:</b> </p> <p>Mean endpoint total score on PANSS (high score = poor)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score PANSS total score in the</p> <p>control group was</p> <p>64.3 + 6.7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score PANSS total score in the intervention group was</p> <p><b>4.1 lower</b><br/>(8.28 lower to 0.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> </p> <p>Attaining normal cognitive functioning ‐ Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on mental state.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning</b>: </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on adverse events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service Use:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on service utilisation.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.43<br/>(0.15 to 1.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>132 per 1,000</b><br/>(46 to 394) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (the study did not report any details regarding random sequence generation and allocation concealment). </p> <p><sup>2</sup> Downgraded by one level (the study did not report any details regarding blinding of participants and assessors). </p> <p><sup>3</sup> Downgraded by one level (the authors have reported attrition in the intervention and control group and the number of participants who left the study early was fewer than 50%. However they have not been clear if the final analysis was done with intention‐to‐treat analysis where the outcome of all young people who were originally randomised were taken into account). </p> <p><sup>4</sup> Downgraded by one level (binary outcome was unavailable. We therefore used continuous scores on CGAS (Global state) and PANSS (mental state) as an alternative indicator). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU compared to TAU (all short‐term) for psychosis in adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009533-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">STRUCTURAL GROUP THERAPY (SGT) + TAU compared to HANDICRAFT GROUP (HC) + TAU (all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>STRUCTURAL GROUP THERAPY + TREATMENT‐AS‐USUAL compared to HANDICRAFT GROUP + TREATMENT‐AS‐USUAL (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Inpatient<br/><b>Intervention:</b> STRUCTURAL GROUP THERAPY + USUAL MEDICATION (SGT + TAU)<br/><b>Comparison:</b> HANDICRAFT GROUP + USUAL MEDICATION (HC + TAU) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with HANDICRAFT GROUP + TREATMENT‐AS‐USUAL (TAU)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with STRUCTURAL GROUP THERAPY + TRAETMENT‐AS‐USUAL (SGT + TAU)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global State:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global state.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental State:</b> </p> <p>Mean endpoint total score on PANSS (high score = poor)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint PANSS score in the control group was</p> <p>55.61 + 3.5</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint PANSS score in the intervention group was</p> <p><b>2.57 lower</b><br/>(4.47 lower to 0.67 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> Attaining normal cognitive functioning ‐ Not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on mental state.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning</b>: </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on adverse events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service Utilisation:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on service utilisation.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.71<br/>(0.25 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>233 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1,000</b><br/>(58 to 467) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (significant number but fewer than 50% of participants were lost to follow‐up over the course of the trial. No mention of intention‐to‐treat analysis was found in the paper). </p> <p><sup>2</sup> Downgraded by one level (binary outcome was unavailable. We therefore used continuous scores on PANSS (mental state) as an alternative indicator). </p> <p>3 Downgraded by one level (data obtained from only one trial that had a small sample size). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">STRUCTURAL GROUP THERAPY (SGT) + TAU compared to HANDICRAFT GROUP (HC) + TAU (all short‐term) for psychosis in adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009533-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">COGNITIVE REMEDIATION PROGRAMME (CRP) + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) compared to PTP (all medium‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME compared to PSYCHOEDUCATIONAL TREATMENT PROGRAMME (all medium‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Inpatient<br/><b>Intervention:</b> COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP)<br/><b>Comparison:</b> PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with PSYCHOEDUCATIONALTREATMENT PROGRAMME (PTP)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Average endpoint score GAS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (GAS) in the control group was</p> <p>47.3 + 9.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (GAS) in the intervention group was <b>1.60 higher</b> </p> <p>(6.48 lower to 9.68 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low </p> <p><sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state:</b> </p> <p>Average endpoint score BPRS (high score = poor)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint BPRS scores in the control group was 43.3 + 14.6</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint BPRS scores in the intervention group was</p> <p><b>5.40 lower</b> </p> <p>(16.42 lower to 5.62 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> </p> <p>Mean endpoint score SPAN‐12 (high score = good)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint score on SPAN scores in the control group was 49.7 + 6.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean endpoint score on SPAN scores in the intervention group was</p> <p><b>2.40 higher</b> </p> <p>(2.67 lower to 7.47 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning:</b> </p> <p>Clinically important change ‐ as defined by each of the studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported useable data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects:</b> </p> <p>Clinically important adverse effect ‐ as defined by each of the studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported useable data on adverse events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service use:</b> </p> <p>Hospital admission for any reason</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported useable data for hospital admission.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early:</b> </p> <p>For any reason</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>For this comparison: no studies reported data for leaving the study early.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (allocation concealment and blinding of participants and raters not well explained). </p> <p><sup>2</sup> Downgraded by one level (the authors analysed various outcome data for variable numbers of participants. Multiple outcome measures were reported but not all measures were completed by all participants. No intention‐to‐treat analysis was conducted and this posed a high risk of bias). </p> <p><sup>3</sup> Downgraded by one level (the sample size for the studies were small. The estimate of effect was not significant with a relatively wide confidence interval that crossed the line of no effect). </p> <p><sup>4</sup> Downgraded by one level (binary outcome was unavailable. We, therefore, employed BPRS score and Global State score as an alternative indicator). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">COGNITIVE REMEDIATION PROGRAMME (CRP) + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (PTP) compared to PTP (all medium‐term) for psychosis in adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009533-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) compared to COMPUTER GAMES (CG, all short‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME compared to COMPUTER GAMES (all short‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Outpatients<br/><b>Intervention:</b> COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR)<br/><b>Comparison:</b> COMPUTER GAMES (CG) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COMPUTER GAMES (CG)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Average endpoint score HoNOSCA (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (HoNOSCA, 8 weeks) in the control group was 16.2 + 6.0 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score (HoNOSCA, 8 weeks) in the intervention group was </p> <p><b>2.0</b> <b>higher</b><br/>(1.85 lower to 5.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state:</b> </p> <p>Average endpoint score PANNS (high score = poor)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint Mental state score (PANNS, 8 weeks) in the control group was 60.9 + 22.7 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint Mental state score (PANNS, 8 weeks) in the intervention group was</p> <p><b>3.7</b> <b>higher</b><br/>(10.68 lower to 18.08 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3, 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cognitive functioning:</b> </p> <p>Average endpoint score RBANS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score RBANS score (8 weeks) in the control group was 92.3 + 14.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint score RBANS score (8 weeks) in the intervention group was</p> <p><b>8.7 lower</b><br/>(17.40 lower to 0.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global functioning</b>: Average endpoint score SOFAS (high score = good) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global functioning score (SOFAS, 8 weeks) in the control group was 52.8 + 10.7 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global functioning score (SOFAS, 8 weeks) in the intervention group was </p> <p><b>0.7 lower</b><br/>(7.76 lower to 6.36 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* data for prespecified outcome of importance: clinically important change (as categorical data) was not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Clinically important change</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Service use:</b> </p> <p>Hospital admission</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.33<br/>(0.27 to 20.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Very Low <sup>1, 2, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1,000</b><br/>(19 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (the participants for the intervention and control arm were trained by the same trainer. The sessions for both the groups were conducted in the same setting with the same frequency and duration. So the trainers and the adolescents were not blind to the group status. This confers high risk of bias, as allocation concealment may have been compromised, as the trainer and the adolescents were aware of the allocation status, although the outcome assessors were blind to the allocation status). </p> <p><sup>2</sup> Downgraded by one level (the sample size of participants randomised was only 24. The magnitude of changes in the mean score of PANSS and HoNOSCA at the endpoint were both small and the confidence intervals were very wide for the mean endpoint scores for both HoNOSCA and BPRS making the results imprecise). </p> <p><sup>3</sup> Downgraded by one level (the study did not report binary outcomes for mental state or cognitive functions. We therefore used continuous scores on HoNOSCA for global state, RBANS ‐ L (language) scores for cognitive functioning and SOFAS for global functioning as an alternative indicator). </p> <p>4 Downgraded by one level (significant number but fewer than 50% of participants were lost to follow‐up over the course of the trial). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) compared to COMPUTER GAMES (CG, all short‐term) for psychosis in adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009533-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">PSYCHOEDUCATIONAL (PE) + MULTIFAMILY TREATMENT (MFT) compared to NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term) for psychosis in adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT compared to NONSTRUCTURED INTERVENTION (all long‐term) for psychosis in adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Adolescents with psychosis<br/><b>Setting:</b> Outpatient<br/><b>Intervention:</b> PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT)<br/><b>Comparison:</b> NONSTRUCTURED GROUP THERAPY (NSGT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NONSTRUCTURED GROUP THERAPY (NSGT)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state:</b> </p> <p>Mean endpoint score CGAS (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score on CGAS (104 weeks) in the control group was 70.67 + 13.6 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint global state score on CGAS (104 weeks) in the intervention group was </p> <p><b>3.38 higher</b><br/>(4.87 lower to 11.63 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental State:</b> </p> <p>Mean end point score PANSS ‐ (high score = good)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score on PANSS (104 weeks) in the control group was 53.58 + 18.23 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean endpoint mental state score on PANSS (104 weeks) in the intervention group was </p> <p><b>8.23 lower</b><br/>(17.51 lower to 1.05 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low <sup>1, 2, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cognitive functioning:</b> Attaining normal cognitive functioning ‐ Not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on mental state.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Global functioning</b>: </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on global functioning.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events:</b> </p> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies reported data on adverse events.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Service use:</b> </p> <p>Number of participants needing admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/>(0.36 to 1.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1,000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>280 per 1,000</b><br/>(120 to 653) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early:</b> For any reason </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.10 to 2.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>55<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1, 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1,000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1,000</b><br/>(14 to 371) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level (therapists were the same for intervention and control groups for each type of clients and were thus not blind to status of the participants increasing the risk of bias). </p> <p><sup>2</sup> Downgraded by one level (although the study stated that the data were analysed using intention‐to‐treat analysis, it was strictly not the case at the end of two years, increasing the risk of bias). </p> <p><sup>3</sup> Downgraded by one level (the magnitude of change in the mean score of CGAS at the endpoint was small and the confidence intervals were very wide for the mean endpoint scores for CGAS, making the results imprecise). </p> <p><sup>4</sup> Downgraded by one level (binary outcome was unavailable. We therefore used continuous scores on CGAS (global state) and PANSS (mental state) as an alternative indicator). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">PSYCHOEDUCATIONAL (PE) + MULTIFAMILY TREATMENT (MFT) compared to NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term) for psychosis in adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/full#CD009533-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009533-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Global state: 1a. Average endpoint score (CGAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐11.05, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mental state: Overall ‐ average endpoint score (PANSS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.30 [0.46, 16.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Cognitive functioning: 1. Clinically important change ‐ not attaining normal cognitive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Memory (Digit span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.37, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Cognitive flexibility (WCST)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.40, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 Planning (Modified Six Elements Test)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.34, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Cognitive functioning: 2. Average endpoint score (various scales, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Verbal Memory (WMS III and RAVLT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐4.47, 6.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Visual Memory (WMS III)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐4.60, 6.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 Working Memory (WISC IV &amp; WAIS III)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐3.66, 6.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.4 Executive Functions (WCST, COWAT &amp; TMT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [‐3.58, 6.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.5 Processing speed (Part A of the TMT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐10.92, 6.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.6 Cognitive Composite Score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐3.70, 4.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Global functioning: 1a. Average endpoint score (Life Skills Profile, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐11.29, 7.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Global functioning: 1b. Average endpoint score (VABS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.90 [‐3.03, 14.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.32, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">COGNITIVE REMEDIATION THERAPY (CRT) + TREATMENT‐AS‐USUAL (TAU) vs TAU (all short‐term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009533-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Global state: average endpoint score (CGAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.10 [1.35, 8.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Mental state: Overall ‐ average endpoint score (PANSS total, high = poor)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.10 [‐8.28, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Quality of life: average endpoint score (PedsQL, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.80 [0.83, 16.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.15, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU (usual medication) vs TAU (usual medicatoin, all short‐term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009533-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.57 [‐4.47, ‐0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐1.66, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.87, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Global functioning: average endpoint score on Self Consistency and Congruence Scale (SCCS, high = good) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 SCSS total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.25, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">STRUCTURAL GROUP THERAPY (SGT) + TAU (usual medication) vs HANDICRAFT GROUP (HC) + TAU (usual medication, all short‐term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009533-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Global state ‐ average endpoint score (GAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [‐6.48, 9.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Mental state: 1a. Overall ‐ average endpoint score (BPRS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.40 [‐16.42, 5.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Mental state: 1b. Overall ‐ average endpoint score (CBCL, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.40 [‐22.98, 18.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Mental state: 2a. Specific: Positive symptoms ‐ average endpoint score (BPRS positive, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐7.95, 3.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Mental state: 2b. Specific: Negative symptoms ‐ average endpoint score (BPRS negative, high = poor ) ‐ (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Cognitive functioning: average endpoint score (various tests, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.1 Attention: Backward Masking Task (BMT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐6.58, 3.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.2 Attention: Span of Apprehension Task (SPAN‐12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.40 [‐2.67, 7.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.3 Attention: Continuous Performance Test (CPT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.70 [‐21.97, 4.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.4 Memory: Kimura Recurring Figures Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐4.48, 6.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.5 Memory: Verbal Learning Paradigm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.80 [‐10.98, 5.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.6 Executive function: WCST perseveration response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [‐4.85, 7.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.7 Executive function: Trail making test ‐ B</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.50 [‐9.07, 18.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">COGNITIVE REMEDIATION PROGRAMME + PSYCHOEDUCATIONAL TREATMENT PROGRAMME (CRP + PTP) vs PTP (all medium‐term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009533-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Global state ‐ average endpoint score (HoNOSCA, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [‐1.85, 5.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [‐10.68, 18.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐2.15, 4.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Mental state: 1c. Negative ‐ average endpoint score (PANSS negative, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [‐4.60, 7.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Cognitive functioning: average endpoint score (RBANS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.1 RBANS total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.70 [‐17.40, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.2 RBANS ‐ A (Attention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐13.36, 9.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.3 RBANS ‐ IM (Immediate Memory)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.90 [‐19.07, 3.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.4 RBANS ‐ DM (Delayed Memory)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.20 [‐16.58, 8.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.5 RBANS ‐ VC (Visuospatial Construction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐9.20, 9.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.6 RBANS ‐ L (Language)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.40 [‐25.42, ‐1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 Global functioning: Overall ‐ average endpoint score (SOFAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐7.76, 6.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.27, 20.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) vs COMPUTER GAMES (CG, all short‐term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009533-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Global state ‐ average endpoint score (CGAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.38 [‐4.87, 11.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.23 [‐17.51, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Mental state: 1b. Specific: Positive symptoms ‐ average endpoint score (PANSS positive, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.85 [‐6.65, 4.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Mental state: 1c. Specific: Negative symptoms ‐ average endpoint score (PANSS negative, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐5.31, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Service use: 1. Hospital admission: number of participants needing addmission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.36, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Service use: 2. Number of days in hospital (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.81 [‐10.13, 6.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.10, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">PSYCHOEDUCATIONAL + MULTIFAMILY TREATMENT (PE + MFT) vs NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009533.pub2/references#CD009533-tbl-0013">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009533.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009533-note-0018">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009533-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009533-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009533-note-0015">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD009533-note-0012">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD009533-note-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD009533-note-0013">Português</a> </li> <li class="section-language"> <a class="" href="th#CD009533-note-0011">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009533\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009533\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009533\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009533\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009533\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009533.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009533.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009533.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009533.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009533.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727356113"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009533.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727356117"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009533.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eaa0b8e8b9377',t:'MTc0MDcyNzM1Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 